{
    "abstract": "Human infections with a novel influenza A H7N9 subtype virus were reported in China recently. The virus caused severe disease with high mortality rates and it raised concerns over its pandemic potential. Here, we assessed in the mouse model protective efficacy of single immunisations with low vaccine doses of insect cell-derived H7 virus-like particles, consisting of hemagglutinin and matrix protein. Vaccinated mice were fully protected and survived a stringent lethal challenge (100. mLD50) with H7N9, even after a single, unadjuvanted, low vaccine dose (0.03. \u03bcg). Serum analysis revealed broad reactivity and hemagglutination inhibition activity across a panel of divergent H7 strains. Moreover, we detected significant levels of cross-reactivity to related group 2 hemagglutinins. These data demonstrate that virus-like particle vaccines have the potential to induce broadly protective immunity against the novel H7N9 virus and a variety of other H7 strains. \u00a9 2013 The Author.",
    "author_highlights": [
        {
            "endOffset": 12193,
            "sentence": "Creation of influenza H7-VLPs containing HAs from A/Shanghai/1/13 or A/Anhui/1/13.",
            "startOffset": 12111
        },
        {
            "endOffset": 12273,
            "sentence": "Single low-dose vaccination is 100% protective against stringent SH1 challenge.",
            "startOffset": 12194
        },
        {
            "endOffset": 12326,
            "sentence": "Single immunisation induces HI titres of up to 1:40.",
            "startOffset": 12274
        },
        {
            "endOffset": 12387,
            "sentence": "Induction of broadly sero-reactive and HI-active antibodies.",
            "startOffset": 12327
        },
        {
            "endOffset": 12464,
            "sentence": "Baculovirus impurities might beneficially contribute to protective efficacy.",
            "startOffset": 12388
        }
    ],
    "bib_entries": {
        "bib0005": null,
        "bib0010": {
            "authors": [
                {
                    "first": "Rongbao",
                    "initial": "R.",
                    "last": "Gao"
                },
                {
                    "first": "Bin",
                    "initial": "B.",
                    "last": "Cao"
                },
                {
                    "first": "Yunwen",
                    "initial": "Y.",
                    "last": "Hu"
                },
                {
                    "first": "Zijian",
                    "initial": "Z.",
                    "last": "Feng"
                },
                {
                    "first": "Dayan",
                    "initial": "D.",
                    "last": "Wang"
                },
                {
                    "first": "Wanfu",
                    "initial": "W.",
                    "last": "Hu"
                },
                {
                    "first": "Jian",
                    "initial": "J.",
                    "last": "Chen"
                },
                {
                    "first": "Zhijun",
                    "initial": "Z.",
                    "last": "Jie"
                },
                {
                    "first": "Haibo",
                    "initial": "H.",
                    "last": "Qiu"
                },
                {
                    "first": "Ke",
                    "initial": "K.",
                    "last": "Xu"
                },
                {
                    "first": "Xuewei",
                    "initial": "X.",
                    "last": "Xu"
                },
                {
                    "first": "Hongzhou",
                    "initial": "H.",
                    "last": "Lu"
                },
                {
                    "first": "Wenfei",
                    "initial": "W.",
                    "last": "Zhu"
                },
                {
                    "first": "Zhancheng",
                    "initial": "Z.",
                    "last": "Gao"
                },
                {
                    "first": "Nijuan",
                    "initial": "N.",
                    "last": "Xiang"
                },
                {
                    "first": "Yinzhong",
                    "initial": "Y.",
                    "last": "Shen"
                },
                {
                    "first": "Zebao",
                    "initial": "Z.",
                    "last": "He"
                },
                {
                    "first": "Yong",
                    "initial": "Y.",
                    "last": "Gu"
                },
                {
                    "first": "Zhiyong",
                    "initial": "Z.",
                    "last": "Zhang"
                },
                {
                    "first": "Yi",
                    "initial": "Y.",
                    "last": "Yang"
                },
                {
                    "first": "Xiang",
                    "initial": "X.",
                    "last": "Zhao"
                },
                {
                    "first": "Lei",
                    "initial": "L.",
                    "last": "Zhou"
                },
                {
                    "first": "Xiaodan",
                    "initial": "X.",
                    "last": "Li"
                },
                {
                    "first": "Shumei",
                    "initial": "S.",
                    "last": "Zou"
                },
                {
                    "first": "Ye",
                    "initial": "Y.",
                    "last": "Zhang"
                },
                {
                    "first": "Xiyan",
                    "initial": "X.",
                    "last": "Li"
                },
                {
                    "first": "Lei",
                    "initial": "L.",
                    "last": "Yang"
                },
                {
                    "first": "Junfeng",
                    "initial": "J.",
                    "last": "Guo"
                },
                {
                    "first": "Jie",
                    "initial": "J.",
                    "last": "Dong"
                },
                {
                    "first": "Qun",
                    "initial": "Q.",
                    "last": "Li"
                },
                {
                    "first": "Libo",
                    "initial": "L.",
                    "last": "Dong"
                },
                {
                    "first": "Yun",
                    "initial": "Y.",
                    "last": "Zhu"
                },
                {
                    "first": "Tian",
                    "initial": "T.",
                    "last": "Bai"
                },
                {
                    "first": "Shiwen",
                    "initial": "S.",
                    "last": "Wang"
                },
                {
                    "first": "Pei",
                    "initial": "P.",
                    "last": "Hao"
                },
                {
                    "first": "Weizhong",
                    "initial": "W.",
                    "last": "Yang"
                },
                {
                    "first": "Yanping",
                    "initial": "Y.",
                    "last": "Zhang"
                },
                {
                    "first": "Jun",
                    "initial": "J.",
                    "last": "Han"
                },
                {
                    "first": "Hongjie",
                    "initial": "H.",
                    "last": "Yu"
                },
                {
                    "first": "Dexin",
                    "initial": "D.",
                    "last": "Li"
                },
                {
                    "first": "George F.",
                    "initial": "G.F.",
                    "last": "Gao"
                },
                {
                    "first": "Guizhen",
                    "initial": "G.",
                    "last": "Wu"
                },
                {
                    "first": "Yu",
                    "initial": "Y.",
                    "last": "Wang"
                },
                {
                    "first": "Zhenghong",
                    "initial": "Z.",
                    "last": "Yuan"
                },
                {
                    "first": "Yuelong",
                    "initial": "Y.",
                    "last": "Shu"
                }
            ],
            "doi": "10.1056/NEJMoa1304459",
            "firstpage": "1888",
            "issn": "00284793",
            "lastpage": "1897",
            "pub_year": 2013,
            "title": "Human infection with a novel avian-origin",
            "volume": "368"
        },
        "bib0015": null,
        "bib0020": {
            "authors": [
                {
                    "first": "Di",
                    "initial": "D.",
                    "last": "Liu"
                },
                {
                    "first": "Weifeng",
                    "initial": "W.",
                    "last": "Shi"
                },
                {
                    "first": "Yi",
                    "initial": "Y.",
                    "last": "Shi"
                },
                {
                    "first": "Dayan",
                    "initial": "D.",
                    "last": "Wang"
                },
                {
                    "first": "Haixia",
                    "initial": "H.",
                    "last": "Xiao"
                },
                {
                    "first": "Wei",
                    "initial": "W.",
                    "last": "Li"
                },
                {
                    "first": "Yuhai",
                    "initial": "Y.",
                    "last": "Bi"
                },
                {
                    "first": "Ying",
                    "initial": "Y.",
                    "last": "Wu"
                },
                {
                    "first": "Xianbin",
                    "initial": "X.",
                    "last": "Li"
                },
                {
                    "first": "Jinghua",
                    "initial": "J.",
                    "last": "Yan"
                },
                {
                    "first": "Wenjun",
                    "initial": "W.",
                    "last": "Liu"
                },
                {
                    "first": "Guoping",
                    "initial": "G.",
                    "last": "Zhao"
                },
                {
                    "first": "Weizhong",
                    "initial": "W.",
                    "last": "Yang"
                },
                {
                    "first": "Yu",
                    "initial": "Y.",
                    "last": "Wang"
                },
                {
                    "first": "Juncai",
                    "initial": "J.",
                    "last": "Ma"
                },
                {
                    "first": "Yuelong",
                    "initial": "Y.",
                    "last": "Shu"
                },
                {
                    "first": "Fumin",
                    "initial": "F.",
                    "last": "Lei"
                },
                {
                    "first": "George F.",
                    "initial": "G.F.",
                    "last": "Gao"
                }
            ],
            "doi": "10.1016/S0140-6736(13)60938-1",
            "firstpage": "1926",
            "issn": "01406736",
            "lastpage": "1932",
            "pub_year": 2013,
            "title": "Origin and diversity of novel avian influenza A H7N9 viruses causing human infection: Phylogenetic, structural, and coalescent analyses",
            "volume": "381"
        },
        "bib0025": null,
        "bib0030": {
            "authors": [
                {
                    "first": "Xuhui",
                    "initial": "X.",
                    "last": "Liu"
                },
                {
                    "first": "Tao",
                    "initial": "T.",
                    "last": "Li"
                },
                {
                    "first": "Yufang",
                    "initial": "Y.",
                    "last": "Zheng"
                },
                {
                    "first": "Ka Wing",
                    "initial": "K.W.",
                    "last": "Wong"
                },
                {
                    "first": "Shuihua",
                    "initial": "S.",
                    "last": "Lu"
                },
                {
                    "first": "Hongzhou",
                    "initial": "H.",
                    "last": "Lu"
                }
            ],
            "doi": "10.1038/emi2013.30",
            "issn": "22221751",
            "pub_year": 2013,
            "title": "Poor responses to oseltamivir treatment in a patient with influenza A (H7N9) virus infection",
            "volume": "2"
        },
        "bib0035": {
            "authors": [
                {
                    "first": "Yunwen",
                    "initial": "Y.",
                    "last": "Hu"
                },
                {
                    "first": "Shuihua",
                    "initial": "S.",
                    "last": "Lu"
                },
                {
                    "first": "Zhigang",
                    "initial": "Z.",
                    "last": "Song"
                },
                {
                    "first": "Wei",
                    "initial": "W.",
                    "last": "Wang"
                },
                {
                    "first": "Pei",
                    "initial": "P.",
                    "last": "Hao"
                },
                {
                    "first": "Jianhua",
                    "initial": "J.",
                    "last": "Li"
                },
                {
                    "first": "Xiaonan",
                    "initial": "X.",
                    "last": "Zhang"
                },
                {
                    "first": "Hui Ling",
                    "initial": "H.L.",
                    "last": "Yen"
                },
                {
                    "first": "Bisheng",
                    "initial": "B.",
                    "last": "Shi"
                },
                {
                    "first": "Tao",
                    "initial": "T.",
                    "last": "Li"
                },
                {
                    "first": "Wencai",
                    "initial": "W.",
                    "last": "Guan"
                },
                {
                    "first": "Lei",
                    "initial": "L.",
                    "last": "Xu"
                },
                {
                    "first": "Yi",
                    "initial": "Y.",
                    "last": "Liu"
                },
                {
                    "first": "Sen",
                    "initial": "S.",
                    "last": "Wang"
                },
                {
                    "first": "Xiaoling",
                    "initial": "X.",
                    "last": "Zhang"
                },
                {
                    "first": "Di",
                    "initial": "D.",
                    "last": "Tian"
                },
                {
                    "first": "Zhaoqin",
                    "initial": "Z.",
                    "last": "Zhu"
                },
                {
                    "first": "Jing",
                    "initial": "J.",
                    "last": "He"
                },
                {
                    "first": "Kai",
                    "initial": "K.",
                    "last": "Huang"
                },
                {
                    "first": "Huijie",
                    "initial": "H.",
                    "last": "Chen"
                },
                {
                    "first": "Lulu",
                    "initial": "L.",
                    "last": "Zheng"
                },
                {
                    "first": "Xuan",
                    "initial": "X.",
                    "last": "Li"
                },
                {
                    "first": "Jie",
                    "initial": "J.",
                    "last": "Ping"
                },
                {
                    "first": "Bin",
                    "initial": "B.",
                    "last": "Kang"
                },
                {
                    "first": "Xiuhong",
                    "initial": "X.",
                    "last": "Xi"
                },
                {
                    "first": "Lijun",
                    "initial": "L.",
                    "last": "Zha"
                },
                {
                    "first": "Yixue",
                    "initial": "Y.",
                    "last": "Li"
                },
                {
                    "first": "Zhiyong",
                    "initial": "Z.",
                    "last": "Zhang"
                },
                {
                    "first": "Malik",
                    "initial": "M.",
                    "last": "Peiris"
                },
                {
                    "first": "Zhenghong",
                    "initial": "Z.",
                    "last": "Yuan"
                }
            ],
            "doi": "10.1016/S0140-6736(13)61125-3",
            "firstpage": "2273",
            "issn": "01406736",
            "lastpage": "2279",
            "pub_year": 2013,
            "title": "Association between adverse clinical outcome in human disease caused by novel influenza A H7N9 virus and sustained viral shedding and emergence of antiviral resistance",
            "volume": "381"
        },
        "bib0040": {
            "authors": [
                {
                    "first": "Emmie",
                    "initial": "E.",
                    "last": "De Wit"
                },
                {
                    "first": "Vincent J.",
                    "initial": "V.J.",
                    "last": "Munster"
                },
                {
                    "first": "Monique I.J.",
                    "initial": "M.I.J.",
                    "last": "Spronken"
                },
                {
                    "first": "Theo M.",
                    "initial": "T.M.",
                    "last": "Bestebroer"
                },
                {
                    "first": "Chantal",
                    "initial": "C.",
                    "last": "Baas"
                },
                {
                    "first": "Walter E.P.",
                    "initial": "W.E.P.",
                    "last": "Beyer"
                },
                {
                    "first": "Guus F.",
                    "initial": "G.F.",
                    "last": "Rimmelzwaan"
                },
                {
                    "first": "Albert D.M.E.",
                    "initial": "A.D.M.E.",
                    "last": "Osterhaus"
                },
                {
                    "first": "Ron A.M.",
                    "initial": "R.A.M.",
                    "last": "Fouchier"
                }
            ],
            "doi": "10.1128/JVI.79.19.12401-12407.2005",
            "firstpage": "12401",
            "issn": "0022538X",
            "lastpage": "12407",
            "pmid": "16160167",
            "pub_year": 2005,
            "title": "Protection of mice against lethal infection with highly pathogenic H7N7 influenza A virus by using a recombinant low-pathogenicity vaccine strain",
            "volume": "79"
        },
        "bib0045": {
            "authors": [
                {
                    "first": "Alison",
                    "initial": "A.",
                    "last": "Whiteley"
                },
                {
                    "first": "Diane",
                    "initial": "D.",
                    "last": "Major"
                },
                {
                    "first": "Isabelle",
                    "initial": "I.",
                    "last": "Legastelois"
                },
                {
                    "first": "Laura",
                    "initial": "L.",
                    "last": "Campitelli"
                },
                {
                    "first": "Isabella",
                    "initial": "I.",
                    "last": "Donatelli"
                },
                {
                    "first": "Catherine I.",
                    "initial": "C.I.",
                    "last": "Thompson"
                },
                {
                    "first": "Maria C.",
                    "initial": "M.C.",
                    "last": "Zambon"
                },
                {
                    "first": "John M.",
                    "initial": "J.M.",
                    "last": "Wood"
                },
                {
                    "first": "Wendy S.",
                    "initial": "W.S.",
                    "last": "Barclay"
                }
            ],
            "doi": "10.1111/j.1750-2659.2007.00022.x",
            "firstpage": "157",
            "issn": "17502659",
            "lastpage": "166",
            "pmid": "19432631",
            "pub_year": 2007,
            "title": "Generation of candidate human influenza vaccine strains in cell culture - rehearsing the European response to an H7N1 pandemic threat.",
            "volume": "1"
        },
        "bib0050": {
            "authors": [
                {
                    "first": "Claudia",
                    "initial": "C.",
                    "last": "Pappas"
                },
                {
                    "first": "Yumiko",
                    "initial": "Y.",
                    "last": "Matsuoka"
                },
                {
                    "first": "David E.",
                    "initial": "D.E.",
                    "last": "Swayne"
                },
                {
                    "first": "Ruben O.",
                    "initial": "R.O.",
                    "last": "Donis"
                }
            ],
            "doi": "10.1128/CVI.00174-07",
            "firstpage": "1425",
            "issn": "15566811",
            "lastpage": "1432",
            "pmid": "17913860",
            "pub_year": 2007,
            "title": "Development and evaluation of an influenza virus subtype H7N2 vaccine candidate for pandemic preparedness",
            "volume": "14"
        },
        "bib0055": {
            "authors": [
                {
                    "first": "Samadhan J.",
                    "initial": "S.J.",
                    "last": "Jadhao"
                },
                {
                    "first": "Jenna",
                    "initial": "J.",
                    "last": "Achenbach"
                },
                {
                    "first": "David E.",
                    "initial": "D.E.",
                    "last": "Swayne"
                },
                {
                    "first": "Ruben",
                    "initial": "R.",
                    "last": "Donis"
                },
                {
                    "first": "Nancy",
                    "initial": "N.",
                    "last": "Cox"
                },
                {
                    "first": "Yumiko",
                    "initial": "Y.",
                    "last": "Matsuoka"
                }
            ],
            "doi": "10.1016/j.vaccine.2008.01.036",
            "firstpage": "1742",
            "issn": "0264410X",
            "lastpage": "1750",
            "pmid": "18336962",
            "pub_year": 2008,
            "title": "Development of Eurasian H7N7/PR8 high growth reassortant virus for clinical evaluation as an inactivated pandemic influenza vaccine",
            "volume": "26"
        },
        "bib0060": {
            "authors": [
                {
                    "first": "Kawsar R.",
                    "initial": "K.R.",
                    "last": "Talaat"
                },
                {
                    "first": "Ruth A.",
                    "initial": "R.A.",
                    "last": "Karron"
                },
                {
                    "first": "Karen A.",
                    "initial": "K.A.",
                    "last": "Callahan"
                },
                {
                    "first": "Catherine J.",
                    "initial": "C.J.",
                    "last": "Luke"
                },
                {
                    "first": "Susan C.",
                    "initial": "S.C.",
                    "last": "DiLorenzo"
                },
                {
                    "first": "Grace L.",
                    "initial": "G.L.",
                    "last": "Chen"
                },
                {
                    "first": "Elaine W.",
                    "initial": "E.W.",
                    "last": "Lamirande"
                },
                {
                    "first": "Hong",
                    "initial": "H.",
                    "last": "Jin"
                },
                {
                    "first": "Kathy L.",
                    "initial": "K.L.",
                    "last": "Coelingh"
                },
                {
                    "first": "Brian R.",
                    "initial": "B.R.",
                    "last": "Murphy"
                },
                {
                    "first": "George",
                    "initial": "G.",
                    "last": "Kemble"
                },
                {
                    "first": "Kanta",
                    "initial": "K.",
                    "last": "Subbarao"
                }
            ],
            "doi": "10.1016/j.vaccine.2009.03.082",
            "firstpage": "3744",
            "issn": "0264410X",
            "lastpage": "3753",
            "pmid": "19464558",
            "pub_year": 2009,
            "title": "A live attenuated H7N3 influenza virus vaccine is well tolerated and immunogenic in a Phase I trial in healthy adults",
            "volume": "27"
        },
        "bib0065": {
            "authors": [
                {
                    "first": "Peter H.",
                    "initial": "P.H.",
                    "last": "Goff"
                },
                {
                    "first": "Florian",
                    "initial": "F.",
                    "last": "Krammer"
                },
                {
                    "first": "Rong",
                    "initial": "R.",
                    "last": "Hai"
                },
                {
                    "first": "Christopher W.",
                    "initial": "C.W.",
                    "last": "Seibert"
                },
                {
                    "first": "Irina",
                    "initial": "I.",
                    "last": "Margine"
                },
                {
                    "first": "Adolfo",
                    "initial": "A.",
                    "last": "Garc\u00eda-Sastre"
                },
                {
                    "first": "Peter",
                    "initial": "P.",
                    "last": "Palesea"
                }
            ],
            "doi": "10.1128/JVI.01085-13",
            "firstpage": "8235",
            "issn": "0022538X",
            "lastpage": "8240",
            "pmid": "23698299",
            "pub_year": 2013,
            "title": "Induction of cross-reactive antibodies to novel H7N9 influenza virus by recombinant newcastle disease virus expressing a north american lineage H7 subtype hemagglutinin",
            "volume": "87"
        },
        "bib0070": {
            "authors": [
                {
                    "first": "Gale E.",
                    "initial": "G.E.",
                    "last": "Smith"
                },
                {
                    "first": "David C.",
                    "initial": "D.C.",
                    "last": "Flyer"
                },
                {
                    "first": "Ramadevi",
                    "initial": "R.",
                    "last": "Raghunandan"
                },
                {
                    "first": "Ye",
                    "initial": "Y.",
                    "last": "Liu"
                },
                {
                    "first": "Ziping",
                    "initial": "Z.",
                    "last": "Wei"
                },
                {
                    "first": "Yingyun",
                    "initial": "Y.",
                    "last": "Wu"
                },
                {
                    "first": "Eloi",
                    "initial": "E.",
                    "last": "Kpamegan"
                },
                {
                    "first": "Denise",
                    "initial": "D.",
                    "last": "Courbron"
                },
                {
                    "first": "Louis F.",
                    "initial": "L.F.",
                    "last": "Fries"
                },
                {
                    "first": "Gregory M.",
                    "initial": "G.M.",
                    "last": "Glenn"
                }
            ],
            "doi": "10.1016/j.vaccine.2013.07.043",
            "firstpage": "4305",
            "issn": "0264410X",
            "lastpage": "4313",
            "pmid": "23891795",
            "pub_year": 2013,
            "title": "Development of influenza H7N9 virus like particle (VLP) vaccine: Homologous A/Anhui/1/2013 (H7N9) protection and heterologous A/chicken/Jalisco/CPA1/2012 (H7N3) cross-protection in vaccinated mice challenged with H7N9 virus",
            "volume": "31"
        },
        "bib0075": {
            "authors": [
                {
                    "first": "Takayuki",
                    "initial": "T.",
                    "last": "Abe"
                },
                {
                    "first": "Hitoshi",
                    "initial": "H.",
                    "last": "Takahashi"
                },
                {
                    "first": "Hiroyuki",
                    "initial": "H.",
                    "last": "Hamazaki"
                },
                {
                    "first": "Naoko",
                    "initial": "N.",
                    "last": "Miyano-Kurosaki"
                },
                {
                    "first": "Yoshiharu",
                    "initial": "Y.",
                    "last": "Matsuura"
                },
                {
                    "first": "Hiroshi",
                    "initial": "H.",
                    "last": "Takaku"
                }
            ],
            "doi": "10.4049/jimmunol.171.3.1133",
            "firstpage": "1133",
            "issn": "00221767",
            "lastpage": "1139",
            "pmid": "12874198",
            "pub_year": 2003,
            "title": "Baculovirus induces an innate immune response and confers protection from lethal influenza virus infection in mice",
            "volume": "171"
        },
        "bib0080": {
            "authors": [
                {
                    "first": "Irina",
                    "initial": "I.",
                    "last": "Margine"
                },
                {
                    "first": "Luis",
                    "initial": "L.",
                    "last": "Martinez-Gil"
                },
                {
                    "first": "Yi ying",
                    "initial": "Y.y.",
                    "last": "Chou"
                },
                {
                    "first": "Florian",
                    "initial": "F.",
                    "last": "Krammer"
                }
            ],
            "doi": "10.1371/journal.pone.0051559",
            "issn": "19326203",
            "pmid": "23236516",
            "pub_year": 2012,
            "title": "Residual Baculovirus in Insect Cell-Derived Influenza Virus-Like Particle Preparations Enhances Immunogenicity",
            "volume": "7"
        },
        "bib0085": {
            "authors": [
                {
                    "first": "Florian",
                    "initial": "F.",
                    "last": "Krammer"
                },
                {
                    "first": "Theresa",
                    "initial": "T.",
                    "last": "Schinko"
                },
                {
                    "first": "Dieter",
                    "initial": "D.",
                    "last": "Palmberger"
                },
                {
                    "first": "Christopher",
                    "initial": "C.",
                    "last": "Tauer"
                },
                {
                    "first": "Paul",
                    "initial": "P.",
                    "last": "Messner"
                },
                {
                    "first": "Reingard",
                    "initial": "R.",
                    "last": "Grabherr"
                }
            ],
            "doi": "10.1007/s12033-010-9268-3",
            "firstpage": "226",
            "issn": "10736085",
            "lastpage": "234",
            "pmid": "20300881",
            "pub_year": 2010,
            "title": "Trichoplusia ni cells (High Five\u2122) are highly efficient for the production of influenza A virus-like particles: A comparison of two insect cell lines as production platforms for influenza vaccines",
            "volume": "45"
        },
        "bib0090": {
            "authors": [
                {
                    "first": "Dieter",
                    "initial": "D.",
                    "last": "Palmberger"
                },
                {
                    "first": "Iain B.H.",
                    "initial": "I.B.H.",
                    "last": "Wilson"
                },
                {
                    "first": "Imre",
                    "initial": "I.",
                    "last": "Berger"
                },
                {
                    "first": "Reingard",
                    "initial": "R.",
                    "last": "Grabherr"
                },
                {
                    "first": "Dubravko",
                    "initial": "D.",
                    "last": "Rendic"
                }
            ],
            "doi": "10.1371/journal.pone.0034226",
            "issn": "19326203",
            "pmid": "22485160",
            "pub_year": 2012,
            "title": "Sweetbac: A new approach for the production of mammalianised glycoproteins in insect cells",
            "volume": "7"
        },
        "bib0095": {
            "authors": [
                {
                    "first": "Ervin",
                    "initial": "E.",
                    "last": "Fodor"
                },
                {
                    "first": "Louise",
                    "initial": "L.",
                    "last": "Devenish"
                },
                {
                    "first": "Othmar G.",
                    "initial": "O.G.",
                    "last": "Engelhardt"
                },
                {
                    "first": "Peter",
                    "initial": "P.",
                    "last": "Palese"
                },
                {
                    "first": "George G.",
                    "initial": "G.G.",
                    "last": "Brownlee"
                },
                {
                    "first": "Adolfo",
                    "initial": "A.",
                    "last": "Garc\u00eda-Sastre"
                }
            ],
            "firstpage": "9679",
            "issn": "0022538X",
            "lastpage": "9682",
            "pmid": "10516084",
            "pub_year": 1999,
            "title": "Rescue of influenza A virus from recombinant DNA",
            "volume": "73"
        },
        "bib0100": {
            "authors": [
                {
                    "first": "Gabriele",
                    "initial": "G.",
                    "last": "Neumann"
                },
                {
                    "first": "Tokiko",
                    "initial": "T.",
                    "last": "Watanabe"
                },
                {
                    "first": "Hiroshi",
                    "initial": "H.",
                    "last": "Ito"
                },
                {
                    "first": "Shinji",
                    "initial": "S.",
                    "last": "Watanabe"
                },
                {
                    "first": "Hideo",
                    "initial": "H.",
                    "last": "Goto"
                },
                {
                    "first": "Peng",
                    "initial": "P.",
                    "last": "Gao"
                },
                {
                    "first": "Mark",
                    "initial": "M.",
                    "last": "Hughes"
                },
                {
                    "first": "Daniel R.",
                    "initial": "D.R.",
                    "last": "Perez"
                },
                {
                    "first": "Ruben",
                    "initial": "R.",
                    "last": "Donis"
                },
                {
                    "first": "Erich",
                    "initial": "E.",
                    "last": "Hoffmann"
                },
                {
                    "first": "Gerd",
                    "initial": "G.",
                    "last": "Hobom"
                },
                {
                    "first": "Yoshihiro",
                    "initial": "Y.",
                    "last": "Kawaoka"
                }
            ],
            "doi": "10.1073/pnas.96.16.9345",
            "firstpage": "9345",
            "issn": "00278424",
            "lastpage": "9350",
            "pmid": "10430945",
            "pub_year": 1999,
            "title": "Generation of influenza A viruses entirely from cloned cDNAs",
            "volume": "96"
        },
        "bib0105": {
            "authors": [
                {
                    "first": "Rong",
                    "initial": "R.",
                    "last": "Hai"
                },
                {
                    "first": "Florian",
                    "initial": "F.",
                    "last": "Krammer"
                },
                {
                    "first": "Gene S.",
                    "initial": "G.S.",
                    "last": "Tan"
                },
                {
                    "first": "Natalie",
                    "initial": "N.",
                    "last": "Pica"
                },
                {
                    "first": "Dirk",
                    "initial": "D.",
                    "last": "Eggink"
                },
                {
                    "first": "Jad",
                    "initial": "J.",
                    "last": "Maamary"
                },
                {
                    "first": "Irina",
                    "initial": "I.",
                    "last": "Margine"
                },
                {
                    "first": "Randy A.",
                    "initial": "R.A.",
                    "last": "Albrecht"
                },
                {
                    "first": "Peter",
                    "initial": "P.",
                    "last": "Palese"
                }
            ],
            "doi": "10.1128/JVI.00137-12",
            "firstpage": "5774",
            "issn": "0022538X",
            "lastpage": "5781",
            "pmid": "22398287",
            "pub_year": 2012,
            "title": "Influenza viruses expressing chimeric hemagglutinins: Globular head and stalk domains derived from different subtypes",
            "volume": "86"
        },
        "bib0110": {
            "authors": [
                {
                    "first": "Florian",
                    "initial": "F.",
                    "last": "Krammer"
                },
                {
                    "first": "Natalie",
                    "initial": "N.",
                    "last": "Pica"
                },
                {
                    "first": "Rong",
                    "initial": "R.",
                    "last": "Hai"
                },
                {
                    "first": "Irina",
                    "initial": "I.",
                    "last": "Margine"
                },
                {
                    "first": "Peter",
                    "initial": "P.",
                    "last": "Palesea"
                }
            ],
            "doi": "10.1128/JVI.00641-13",
            "firstpage": "6542",
            "issn": "0022538X",
            "lastpage": "6550",
            "pmid": "23576508",
            "pub_year": 2013,
            "title": "Chimeric hemagglutinin influenza virus vaccine constructs elicit broadly protective stalk-specific antibodies",
            "volume": "87"
        },
        "bib0115": {
            "authors": [
                {
                    "first": "Florian",
                    "initial": "F.",
                    "last": "Krammer"
                },
                {
                    "first": "Irina",
                    "initial": "I.",
                    "last": "Margine"
                },
                {
                    "first": "Gene S.",
                    "initial": "G.S.",
                    "last": "Tan"
                },
                {
                    "first": "Natalie",
                    "initial": "N.",
                    "last": "Pica"
                },
                {
                    "first": "Jens C.",
                    "initial": "J.C.",
                    "last": "Krause"
                },
                {
                    "first": "Peter",
                    "initial": "P.",
                    "last": "Palese"
                }
            ],
            "doi": "10.1371/journal.pone.0043603",
            "issn": "19326203",
            "pmid": "22928001",
            "pub_year": 2012,
            "title": "A carboxy-terminal trimerization domain stabilizes conformational epitopes on the stalk domain of soluble recombinant Hemagglutinin substrates",
            "volume": "7"
        },
        "bib0120": null,
        "bib0125": {
            "authors": [
                {
                    "first": "Mohamad Labib",
                    "initial": "M.L.",
                    "last": "Salem"
                },
                {
                    "first": "Mohammad Sohrab",
                    "initial": "M.S.",
                    "last": "Hossain"
                }
            ],
            "doi": "10.1016/S0192-0561(00)00033-3",
            "firstpage": "707",
            "issn": "01920561",
            "lastpage": "718",
            "pmid": "10884591",
            "pub_year": 2000,
            "title": "In vivo acute depletion of CD8+ T cells before murine cytomegalovirus infection upregulated innate antiviral activity of natural killer cells",
            "volume": "22"
        },
        "bib0130": {
            "authors": [
                {
                    "first": "Emily A.",
                    "initial": "E.A.",
                    "last": "Hemann"
                },
                {
                    "first": "Sang Moo",
                    "initial": "S.M.",
                    "last": "Kang"
                },
                {
                    "first": "Kevin L.",
                    "initial": "K.L.",
                    "last": "Legge"
                }
            ],
            "doi": "10.4049/jimmunol.1300954",
            "firstpage": "2486",
            "issn": "00221767",
            "lastpage": "2494",
            "pmid": "23885108",
            "pub_year": 2013,
            "title": "Protective CD8 T cell-mediated immunity against influenza a virus infection following influenza virus-like particle vaccination",
            "volume": "191"
        },
        "bib0135": {
            "authors": [
                {
                    "first": "Marine L.B.",
                    "initial": "M.L.B.",
                    "last": "Hillaire"
                },
                {
                    "first": "Albert D.M.E.",
                    "initial": "A.D.M.E.",
                    "last": "Osterhaus"
                },
                {
                    "first": "Guus F.",
                    "initial": "G.F.",
                    "last": "Rimmelzwaan"
                }
            ],
            "doi": "10.1155/2011/939860",
            "issn": "11107243",
            "pmid": "22007149",
            "pub_year": 2011,
            "title": "Induction of virus-specific cytotoxic T lymphocytes as a basis for the development of broadly protective influenza vaccines",
            "volume": "2011"
        },
        "bib0140": {
            "authors": [
                {
                    "first": "Tomy",
                    "initial": "T.",
                    "last": "Joseph"
                },
                {
                    "first": "Josephine",
                    "initial": "J.",
                    "last": "McAuliffe"
                },
                {
                    "first": "Bin",
                    "initial": "B.",
                    "last": "Lu"
                },
                {
                    "first": "Hong",
                    "initial": "H.",
                    "last": "Jin"
                },
                {
                    "first": "George",
                    "initial": "G.",
                    "last": "Kemble"
                },
                {
                    "first": "Kanta",
                    "initial": "K.",
                    "last": "Subbarao"
                }
            ],
            "doi": "10.1128/JVI.00970-07",
            "firstpage": "10558",
            "issn": "0022538X",
            "lastpage": "10566",
            "pmid": "17634234",
            "pub_year": 2007,
            "title": "Evaluation of replication and pathogenicity of avian influenza A H7 subtype viruses in a mouse model",
            "volume": "81"
        },
        "bib0145": {
            "authors": [
                {
                    "first": "Michael T.",
                    "initial": "M.T.",
                    "last": "Osterholm"
                },
                {
                    "first": "Katie S.",
                    "initial": "K.S.",
                    "last": "Ballering"
                },
                {
                    "first": "Nicholas S.",
                    "initial": "N.S.",
                    "last": "Kelley"
                }
            ],
            "doi": "10.1001/jama.2013.6589",
            "firstpage": "2557",
            "issn": "00987484",
            "lastpage": "2558",
            "pmid": "23700117",
            "pub_year": 2013,
            "title": "Major challenges in providing an effective and timely pandemic vaccine for influenza A(H7N9)",
            "volume": "309"
        },
        "bib0150": {
            "authors": [
                {
                    "first": "Benjamin J.",
                    "initial": "B.J.",
                    "last": "Cowling"
                },
                {
                    "first": "Lianmei",
                    "initial": "L.",
                    "last": "Jin"
                },
                {
                    "first": "Eric H.Y.",
                    "initial": "E.H.Y.",
                    "last": "Lau"
                },
                {
                    "first": "Qiaohong",
                    "initial": "Q.",
                    "last": "Liao"
                },
                {
                    "first": "Peng",
                    "initial": "P.",
                    "last": "Wu"
                },
                {
                    "first": "Hui",
                    "initial": "H.",
                    "last": "Jiang"
                },
                {
                    "first": "Tim K.",
                    "initial": "T.K.",
                    "last": "Tsang"
                },
                {
                    "first": "Jiandong",
                    "initial": "J.",
                    "last": "Zheng"
                },
                {
                    "first": "Vicky J.",
                    "initial": "V.J.",
                    "last": "Fang"
                },
                {
                    "first": "Zhaorui",
                    "initial": "Z.",
                    "last": "Chang"
                },
                {
                    "first": "Michael Y.",
                    "initial": "M.Y.",
                    "last": "Ni"
                },
                {
                    "first": "Qian",
                    "initial": "Q.",
                    "last": "Zhang"
                },
                {
                    "first": "Dennis K.M.",
                    "initial": "D.K.M.",
                    "last": "Ip"
                },
                {
                    "first": "Jianxing",
                    "initial": "J.",
                    "last": "Yu"
                },
                {
                    "first": "Yu",
                    "initial": "Y.",
                    "last": "Li"
                },
                {
                    "first": "Liping",
                    "initial": "L.",
                    "last": "Wang"
                },
                {
                    "first": "Wenxiao",
                    "initial": "W.",
                    "last": "Tu"
                },
                {
                    "first": "Ling",
                    "initial": "L.",
                    "last": "Meng"
                },
                {
                    "first": "Joseph T.",
                    "initial": "J.T.",
                    "last": "Wu"
                },
                {
                    "first": "Huiming",
                    "initial": "H.",
                    "last": "Luo"
                },
                {
                    "first": "Qun",
                    "initial": "Q.",
                    "last": "Li"
                },
                {
                    "first": "Yuelong",
                    "initial": "Y.",
                    "last": "Shu"
                },
                {
                    "first": "Zhongjie",
                    "initial": "Z.",
                    "last": "Li"
                },
                {
                    "first": "Zijian",
                    "initial": "Z.",
                    "last": "Feng"
                },
                {
                    "first": "Weizhong",
                    "initial": "W.",
                    "last": "Yang"
                },
                {
                    "first": "Yu",
                    "initial": "Y.",
                    "last": "Wang"
                },
                {
                    "first": "Gabriel M.",
                    "initial": "G.M.",
                    "last": "Leung"
                },
                {
                    "first": "Hongjie",
                    "initial": "H.",
                    "last": "Yu"
                }
            ],
            "doi": "10.1016/S0140-6736(13)61171-X",
            "firstpage": "129",
            "issn": "01406736",
            "lastpage": "137",
            "pmid": "23803488",
            "pub_year": 2013,
            "title": "Comparative epidemiology of human infections with avian influenza A H7N9 and H5N1 viruses in China: A population-based study of laboratory-confirmed cases",
            "volume": "382"
        },
        "bib0155": {
            "authors": [
                {
                    "first": "Gary Ro Lin",
                    "initial": "G.R.L.",
                    "last": "Chang"
                },
                {
                    "first": "Su Yuan",
                    "initial": "S.Y.",
                    "last": "Lai"
                },
                {
                    "first": "Poa Chun",
                    "initial": "P.C.",
                    "last": "Chang"
                },
                {
                    "first": "Min Ying",
                    "initial": "M.Y.",
                    "last": "Wang"
                }
            ],
            "doi": "10.1016/j.procbio.2011.02.019",
            "firstpage": "1292",
            "issn": "13595113",
            "lastpage": "1298",
            "pub_year": 2011,
            "title": "Production of immunogenic one-component avian H7-subtype influenza virus-like particles",
            "volume": "46"
        },
        "bib0160": {
            "authors": [
                {
                    "first": "Tomy",
                    "initial": "T.",
                    "last": "Joseph"
                },
                {
                    "first": "Josephine",
                    "initial": "J.",
                    "last": "McAuliffe"
                },
                {
                    "first": "Bin",
                    "initial": "B.",
                    "last": "Lu"
                },
                {
                    "first": "Leatrice",
                    "initial": "L.",
                    "last": "Vogel"
                },
                {
                    "first": "David",
                    "initial": "D.",
                    "last": "Swayne"
                },
                {
                    "first": "Hong",
                    "initial": "H.",
                    "last": "Jin"
                },
                {
                    "first": "George",
                    "initial": "G.",
                    "last": "Kemble"
                },
                {
                    "first": "Kanta",
                    "initial": "K.",
                    "last": "Subbarao"
                }
            ],
            "doi": "10.1016/j.virol.2008.05.021",
            "firstpage": "123",
            "issn": "00426822",
            "lastpage": "132",
            "pmid": "18585748",
            "pub_year": 2008,
            "title": "A live attenuated cold-adapted influenza A H7N3 virus vaccine provides protection against homologous and heterologous H7 viruses in mice and ferrets",
            "volume": "378"
        },
        "bib0165": null,
        "bib0170": {
            "authors": [
                {
                    "first": "Rebecca J.",
                    "initial": "R.J.",
                    "last": "Cox"
                },
                {
                    "first": "Abdullah S.",
                    "initial": "A.S.",
                    "last": "Madhun"
                },
                {
                    "first": "Solveig",
                    "initial": "S.",
                    "last": "Hauge"
                },
                {
                    "first": "Haakon",
                    "initial": "H.",
                    "last": "Sjursen"
                },
                {
                    "first": "Diane",
                    "initial": "D.",
                    "last": "Major"
                },
                {
                    "first": "Mirjam",
                    "initial": "M.",
                    "last": "Kuhne"
                },
                {
                    "first": "Katja",
                    "initial": "K.",
                    "last": "H\u00f6schler"
                },
                {
                    "first": "Melanie",
                    "initial": "M.",
                    "last": "Saville"
                },
                {
                    "first": "Frederick R.",
                    "initial": "F.R.",
                    "last": "Vogel"
                },
                {
                    "first": "Wendy",
                    "initial": "W.",
                    "last": "Barclay"
                },
                {
                    "first": "Isabella",
                    "initial": "I.",
                    "last": "Donatelli"
                },
                {
                    "first": "Maria",
                    "initial": "M.",
                    "last": "Zambon"
                },
                {
                    "first": "John",
                    "initial": "J.",
                    "last": "Wood"
                },
                {
                    "first": "Lars R.",
                    "initial": "L.R.",
                    "last": "Haaheim"
                }
            ],
            "doi": "10.1016/j.vaccine.2009.01.116",
            "firstpage": "1889",
            "issn": "0264410X",
            "lastpage": "1897",
            "pmid": "19368768",
            "pub_year": 2009,
            "title": "A phase I clinical trial of a PER.C6\u00ae cell grown influenza H7 virus vaccine",
            "volume": "27"
        },
        "bib0175": {
            "authors": [
                {
                    "first": "Robert B.",
                    "initial": "R.B.",
                    "last": "Couch"
                },
                {
                    "first": "Shital M.",
                    "initial": "S.M.",
                    "last": "Patel"
                },
                {
                    "first": "Chianti L.",
                    "initial": "C.L.",
                    "last": "Wade-Bowers"
                },
                {
                    "first": "Diane",
                    "initial": "D.",
                    "last": "Ni\u00f1o"
                }
            ],
            "doi": "10.1371/journal.pone.0049704",
            "issn": "19326203",
            "pmid": "23239968",
            "pub_year": 2012,
            "title": "A Randomized Clinical Trial of an Inactivated Avian Influenza A (H7N7) Vaccine",
            "volume": "7"
        },
        "bib0180": {
            "authors": [
                {
                    "first": "Jeffrey",
                    "initial": "J.",
                    "last": "Partridge"
                },
                {
                    "first": "Marie Paule",
                    "initial": "M.P.",
                    "last": "Kieny"
                }
            ],
            "doi": "10.1016/j.vaccine.2012.10.111",
            "firstpage": "728",
            "issn": "0264410X",
            "lastpage": "731",
            "pmid": "23149268",
            "pub_year": 2013,
            "title": "Global production capacity of seasonal influenza vaccine in 2011",
            "volume": "31"
        },
        "bib0185": null,
        "bib0190": {
            "authors": [
                {
                    "first": "Jie",
                    "initial": "J.",
                    "last": "Sun"
                },
                {
                    "first": "Thomas J.",
                    "initial": "T.J.",
                    "last": "Braciale"
                }
            ],
            "doi": "10.1016/j.coviro.2013.05.001",
            "firstpage": "425",
            "issn": "18796257",
            "lastpage": "429",
            "pub_year": 2013,
            "title": "Role of T cell immunity in recovery from influenza virus infection",
            "volume": "3"
        },
        "bib0195": {
            "authors": [
                {
                    "first": "Bradley S.",
                    "initial": "B.S.",
                    "last": "Bender"
                },
                {
                    "first": "Thomas",
                    "initial": "T.",
                    "last": "Croghan"
                },
                {
                    "first": "Liping",
                    "initial": "L.",
                    "last": "Zhang"
                },
                {
                    "first": "Parker A.",
                    "initial": "P.A.",
                    "last": "Small"
                }
            ],
            "doi": "10.1084/jem.175.4.1143",
            "firstpage": "1143",
            "issn": "00221007",
            "lastpage": "1145",
            "pmid": "1552285",
            "pub_year": 1992,
            "title": "Transgenic mice lacking class i major histocompatibility complex-restricted t cells have delayed viral clearance and increased mortality after influenza virus challenge",
            "volume": "175"
        },
        "bib0200": {
            "authors": [
                {
                    "first": "W.",
                    "initial": "W.",
                    "last": "Gerhard"
                }
            ],
            "firstpage": "171",
            "issn": "0070217X",
            "lastpage": "190",
            "pmid": "11443873",
            "pub_year": 2001,
            "title": "The role of the antibody response in influenza virus infection",
            "volume": "260"
        },
        "bib0205": {
            "authors": [
                {
                    "first": "Rafael",
                    "initial": "R.",
                    "last": "Cubas"
                },
                {
                    "first": "Sheng",
                    "initial": "S.",
                    "last": "Zhang"
                },
                {
                    "first": "Sunkuk",
                    "initial": "S.",
                    "last": "Kwon"
                },
                {
                    "first": "Eva M.",
                    "initial": "E.M.",
                    "last": "Sevick-Muraca"
                },
                {
                    "first": "Min",
                    "initial": "M.",
                    "last": "Li"
                },
                {
                    "first": "Changyi",
                    "initial": "C.",
                    "last": "Chen"
                },
                {
                    "first": "Qizhi",
                    "initial": "Q.",
                    "last": "Yao"
                }
            ],
            "doi": "10.1097/CJI.0b013e31818f13c4",
            "firstpage": "118",
            "issn": "15249557",
            "lastpage": "128",
            "pmid": "19238010",
            "pub_year": 2009,
            "title": "Virus-like particle (VLP) lymphatic trafficking and immune response generation after immunization by different routes",
            "volume": "32"
        },
        "bib0210": {
            "authors": [
                {
                    "first": "Mieko",
                    "initial": "M.",
                    "last": "Muramatsu"
                },
                {
                    "first": "Reiko",
                    "initial": "R.",
                    "last": "Yoshida"
                },
                {
                    "first": "Hiroko",
                    "initial": "H.",
                    "last": "Miyamoto"
                },
                {
                    "first": "Daisuke",
                    "initial": "D.",
                    "last": "Tomabechi"
                },
                {
                    "first": "Masahiro",
                    "initial": "M.",
                    "last": "Kajihara"
                },
                {
                    "first": "Junki",
                    "initial": "J.",
                    "last": "Maruyama"
                },
                {
                    "first": "Takashi",
                    "initial": "T.",
                    "last": "Kimura"
                },
                {
                    "first": "Rashid",
                    "initial": "R.",
                    "last": "Manzoor"
                },
                {
                    "first": "Kimihito",
                    "initial": "K.",
                    "last": "Ito"
                },
                {
                    "first": "Ayato",
                    "initial": "A.",
                    "last": "Takada"
                }
            ],
            "doi": "10.1371/journal.pone.0071534",
            "issn": "19326203",
            "pmid": "23977065",
            "pub_year": 2013,
            "title": "Heterosubtypic Antiviral Activity of Hemagglutinin-Specific Antibodies Induced by Intranasal Immunization with Inactivated Influenza Viruses in Mice",
            "volume": "8"
        },
        "bib0215": {
            "authors": [
                {
                    "first": "I.",
                    "initial": "I.",
                    "last": "Margine"
                },
                {
                    "first": "F.",
                    "initial": "F.",
                    "last": "Krammer"
                },
                {
                    "first": "R.",
                    "initial": "R.",
                    "last": "Hai"
                },
                {
                    "first": "N. S.",
                    "initial": "N.S.",
                    "last": "Heaton"
                },
                {
                    "first": "G. S.",
                    "initial": "G.S.",
                    "last": "Tan"
                },
                {
                    "first": "S. A.",
                    "initial": "S.A.",
                    "last": "Andrews"
                },
                {
                    "first": "J. A.",
                    "initial": "J.A.",
                    "last": "Runstadler"
                },
                {
                    "first": "P. C.",
                    "initial": "P.C.",
                    "last": "Wilson"
                },
                {
                    "first": "R. A.",
                    "initial": "R.A.",
                    "last": "Albrecht"
                },
                {
                    "first": "A.",
                    "initial": "A.",
                    "last": "Garc\u00eda-Sastre"
                },
                {
                    "first": "P.",
                    "initial": "P.",
                    "last": "Palesea"
                }
            ],
            "doi": "10.1128/JVI.01715-13",
            "firstpage": "10435",
            "issn": "0022538X",
            "lastpage": "10446",
            "pmid": "23903831",
            "pub_year": 2013,
            "title": "Hemagglutinin stalk-based universal vaccine constructs protect against group 2 influenza A viruses",
            "volume": "87"
        },
        "bib0220": {
            "authors": [
                {
                    "first": "Muhammad Athar",
                    "initial": "M.A.",
                    "last": "Abbas"
                },
                {
                    "first": "Erica",
                    "initial": "E.",
                    "last": "Spackman"
                },
                {
                    "first": "Ron",
                    "initial": "R.",
                    "last": "Fouchier"
                },
                {
                    "first": "Derek",
                    "initial": "D.",
                    "last": "Smith"
                },
                {
                    "first": "Zaheer",
                    "initial": "Z.",
                    "last": "Ahmed"
                },
                {
                    "first": "Naila",
                    "initial": "N.",
                    "last": "Siddique"
                },
                {
                    "first": "Luciana",
                    "initial": "L.",
                    "last": "Sarmento"
                },
                {
                    "first": "Khalid",
                    "initial": "K.",
                    "last": "Naeem"
                },
                {
                    "first": "Enid T.",
                    "initial": "E.T.",
                    "last": "McKinley"
                },
                {
                    "first": "Abdul",
                    "initial": "A.",
                    "last": "Hameed"
                },
                {
                    "first": "Shafqat",
                    "initial": "S.",
                    "last": "Rehmani"
                },
                {
                    "first": "David E.",
                    "initial": "D.E.",
                    "last": "Swayne"
                }
            ],
            "doi": "10.1016/j.vaccine.2011.07.064",
            "firstpage": "7424",
            "issn": "0264410X",
            "lastpage": "7429",
            "pmid": "21803098",
            "pub_year": 2011,
            "title": "H7 avian influenza virus vaccines protect chickens against challenge with antigenically diverse isolates",
            "volume": "29"
        },
        "bib0225": {
            "authors": [
                {
                    "first": "Fang",
                    "initial": "F.",
                    "last": "He"
                },
                {
                    "first": "Selvaraj",
                    "initial": "S.",
                    "last": "Madhan"
                },
                {
                    "first": "Jimmy",
                    "initial": "J.",
                    "last": "Kwang"
                }
            ],
            "doi": "10.1586/erv.09.2",
            "firstpage": "455",
            "issn": "14760584",
            "lastpage": "467",
            "pmid": "19348561",
            "pub_year": 2009,
            "title": "Baculovirus vector as a delivery vehicle for influenza vaccines",
            "volume": "8"
        },
        "bib0230": {
            "authors": [
                {
                    "first": "Jae Min",
                    "initial": "J.M.",
                    "last": "Song"
                },
                {
                    "first": "Chi Won",
                    "initial": "C.W.",
                    "last": "Choi"
                },
                {
                    "first": "Sang Oh",
                    "initial": "S.O.",
                    "last": "Kwon"
                },
                {
                    "first": "Richard W.",
                    "initial": "R.W.",
                    "last": "Compans"
                },
                {
                    "first": "Sang Moo",
                    "initial": "S.M.",
                    "last": "Kang"
                },
                {
                    "first": "Seung Il",
                    "initial": "S.I.",
                    "last": "Kim"
                }
            ],
            "doi": "10.1021/pr200086v",
            "firstpage": "3450",
            "issn": "15353893",
            "lastpage": "3459",
            "pmid": "21688770",
            "pub_year": 2011,
            "title": "Proteomic characterization of influenza H5N1 virus-like particles and their protective immunogenicity",
            "volume": "10"
        },
        "bib0235": {
            "authors": [
                {
                    "first": "Christine M.",
                    "initial": "C.M.",
                    "last": "Thompson"
                },
                {
                    "first": "Emma",
                    "initial": "E.",
                    "last": "Petiot"
                },
                {
                    "first": "Alexandre",
                    "initial": "A.",
                    "last": "Lennaertz"
                },
                {
                    "first": "Olivier",
                    "initial": "O.",
                    "last": "Henry"
                },
                {
                    "first": "Amine A.",
                    "initial": "A.A.",
                    "last": "Kamen"
                }
            ],
            "doi": "10.1186/1743-422X-10-141",
            "issn": "1743422X",
            "pub_year": 2013,
            "title": "Analytical technologies for influenza virus-like particle candidate vaccines: Challenges and emerging approaches",
            "volume": "10"
        }
    },
    "body_text": [
        {
            "endOffset": 23136,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "sec0040",
            "sentence": "After infection, the samples were removed and cells were overlaid with 2 mL of a solution containing 1% agarose in TNM-FH, 10% (v/v) foetal bovine serum, Penicillin\u2013Streptomycin antibiotic mixture pre-warmed to 37 \u00b0C.",
            "startOffset": 22919,
            "title": "Quantification of baculovirus content in the vaccine preparation"
        },
        {
            "endOffset": 24958,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "sec0050",
            "sentence": "The prime-only group was immunised once with SH1-VLPs at a dose of 0.03 \u03bcg, 0.3 \u03bcg or 3 \u03bcg based on HA content in PBS or with 0.3 \u03bcg AH1-VLPs in a volume of 50 \u03bcL intramuscularly (i.m.) in the calf muscle (N = 5 per vaccine dose) at day 0.",
            "startOffset": 24719,
            "title": "Mouse immunisation and challenge"
        },
        {
            "endOffset": 23814,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "sec0045",
            "sentence": "M1-VLPs served as a negative control and were adjusted to a total protein concentration equal to that of SH1-VLP (0.3 \u03bcg HA content) as measured using the Quickstart Bradford Dye Reagent (Bio-Rad, Hercules, CA) with bovine serum albumin as standard.",
            "startOffset": 23565,
            "title": "Vaccine formulation"
        },
        {
            "endOffset": 36872,
            "parents": [],
            "refoffsets": {
                "bib0185": {
                    "endOffset": 36871,
                    "startOffset": 36867
                }
            },
            "secId": "sec0085",
            "sentence": "Development of more efficient vaccines is a key objective defined by the Global Action Plan for Influenza vaccines by the WHO [37].",
            "startOffset": 36741,
            "title": "Discussion"
        },
        {
            "endOffset": 17673,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "sec0020",
            "sentence": "Recombinant A/Puerto Rico/8/34 (PR8) viruses (6:2) were generated that expressed HA and NA of human H7N9 viruses from the current outbreak in China, including A/Shanghai/1/13 (abbreviated PR8:SH1) and A/Anhui/1/13 (PR8:AH1).",
            "startOffset": 17449,
            "title": "Viruses"
        },
        {
            "endOffset": 25712,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "sec0050",
            "sentence": "Mice were then infected with 100 LD50 of the recombinant virus PR8:SH1.",
            "startOffset": 25641,
            "title": "Mouse immunisation and challenge"
        },
        {
            "endOffset": 43273,
            "parents": [],
            "secId": "sec0090",
            "sentence": "In addition it would be necessary to assess the minimum effective concentration of baculovirus in a vaccine dose and to establish an acceptable HA or VLP to active baculovirus ratio.",
            "startOffset": 43091,
            "title": "Conclusion"
        },
        {
            "endOffset": 16313,
            "parents": [],
            "secId": "sec0005",
            "sentence": "Even the lowest tested vaccine doses conferred full protection against the stringent viral challenge.",
            "startOffset": 16212,
            "title": "Introduction"
        },
        {
            "endOffset": 14282,
            "parents": [],
            "secId": "sec0005",
            "sentence": "Efforts to restrict avian to human transmission were initiated including shutting down large poultry markets throughout the country.",
            "startOffset": 14150,
            "title": "Introduction"
        },
        {
            "endOffset": 31600,
            "parents": [
                {
                    "id": "sec0065",
                    "title": "Results"
                }
            ],
            "secId": "sec0070",
            "sentence": "Mice vaccinated with AH1-VLPs lost slightly more weight than mice that received the same dose of SH1-VLPs (0.3 \u03bcg of HA) but were fully protected from mortality (Fig. 1A and C).",
            "startOffset": 31423,
            "title": "Efficacy of H7-VLPs in an in vivo mouse challenge experiment"
        },
        {
            "endOffset": 21185,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "sec0030",
            "sentence": "Membranes were washed three times with PBST and incubated for 1 h at room temperature with a horseradish-peroxidase-conjugated goat anti-mouse IgG (H + L) secondary antibody (Santa Cruz Biotechnology, Inc., Dallas, TX) at a dilution of 1:2000.",
            "startOffset": 20942,
            "title": "Western blot analysis and HA quantification"
        },
        {
            "endOffset": 19641,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "sec0025",
            "sentence": "Briefly, the synthetic genes were cloned into a modified pFastBacDual baculovirus transfer vector and recombinant bacmids were constructed using the Bac-to-Bac System (Invitrogen, Carlsbad, CA).",
            "startOffset": 19447,
            "title": "Production of virus-like particles in insect cells"
        },
        {
            "endOffset": 37713,
            "parents": [],
            "secId": "sec0085",
            "sentence": "Since the VLPs used in their study were highly purified we would speculate that active baculovirus contaminants in our vaccine preparations (supplementary data) acted as an adjuvant and boosted the immune response \u2013 an effect that was reported before.",
            "startOffset": 37462,
            "title": "Discussion"
        },
        {
            "endOffset": 15786,
            "parents": [],
            "secId": "sec0005",
            "sentence": "Hence, in order to keep the by-product in the vaccine formulation, we concentrated the VLPs and residual baculovirus from the culture supernatant by one-step sucrose-cushion purification.",
            "startOffset": 15599,
            "title": "Introduction"
        },
        {
            "endOffset": 16212,
            "parents": [],
            "secId": "sec0005",
            "sentence": "Pre-challenge serum was evaluated for the breadth of reactivity and hemagglutination inhibition (HI) activity of the elicited humoral response to divergent H7 HAs, as well as representatives of all group 2 HA subtypes.",
            "startOffset": 15994,
            "title": "Introduction"
        },
        {
            "endOffset": 32812,
            "parents": [
                {
                    "id": "sec0065",
                    "title": "Results"
                }
            ],
            "secId": "sec0075",
            "sentence": "An H1 HA (group 1) was added as a negative control antigen.",
            "startOffset": 32753,
            "title": "H7 VLP vaccines induce broadly reactive antibodies"
        },
        {
            "endOffset": 23564,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "sec0045",
            "sentence": "The AH1-VLP vaccine was prepared at a single concentration (0.3 \u03bcg AH1-HA per 50 \u03bcL).",
            "startOffset": 23479,
            "title": "Vaccine formulation"
        },
        {
            "endOffset": 30889,
            "parents": [
                {
                    "id": "sec0065",
                    "title": "Results"
                }
            ],
            "refoffsets": {
                "bib0020": {
                    "endOffset": 30888,
                    "startOffset": 30885
                }
            },
            "secId": "sec0070",
            "sentence": "To explore whether a prime-only strategy could protect against a heterologous strain as well, we included a VLP formulation that contained HA of AH1, a divergent H7N9 isolate. [4].",
            "startOffset": 30709,
            "title": "Efficacy of H7-VLPs in an in vivo mouse challenge experiment"
        },
        {
            "endOffset": 33347,
            "parents": [
                {
                    "id": "sec0065",
                    "title": "Results"
                }
            ],
            "secId": "sec0075",
            "sentence": "Good correlation could be drawn between vaccine dose and total IgG levels to homologous and heterologous H7 strains as seen by the dose-dependent decrease of antibody levels in most cases.",
            "startOffset": 33159,
            "title": "H7 VLP vaccines induce broadly reactive antibodies"
        },
        {
            "endOffset": 41246,
            "parents": [],
            "secId": "sec0085",
            "sentence": "This may be due to the utilisation of individual versus pooled sera in the assays.",
            "startOffset": 41164,
            "title": "Discussion"
        },
        {
            "endOffset": 38217,
            "parents": [],
            "refoffsets": {
                "bib0190": {
                    "endOffset": 38216,
                    "startOffset": 38212
                }
            },
            "secId": "sec0085",
            "sentence": "Generally, T-lymphocytes have long been appreciated as a critical contributor to protection and recovery from influenza infection [38].",
            "startOffset": 38082,
            "title": "Discussion"
        },
        {
            "endOffset": 21551,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "sec0030",
            "sentence": "Radiographs were developed on a SRX-101A processor (Konica Minolta, Osaka, Japan).",
            "startOffset": 21469,
            "title": "Western blot analysis and HA quantification"
        },
        {
            "endOffset": 21711,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "sec0030",
            "sentence": "HA content of the VLP samples was determined densitometrically against known concentrations of the SH1-HA protein using ImageJ (National Institutes of Health).",
            "startOffset": 21552,
            "title": "Western blot analysis and HA quantification"
        },
        {
            "endOffset": 19788,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "sec0025",
            "sentence": "VLPs were expressed in High Five cells using Fernbach flasks incubated at 27 \u00b0C.",
            "startOffset": 19708,
            "title": "Production of virus-like particles in insect cells"
        },
        {
            "endOffset": 41048,
            "parents": [],
            "refoffsets": {
                "bib0065": {
                    "endOffset": 41008,
                    "startOffset": 41004
                },
                "bib0070": {
                    "endOffset": 41030,
                    "startOffset": 41026
                },
                "bib0220": {
                    "endOffset": 40967,
                    "startOffset": 40963
                }
            },
            "secId": "sec0085",
            "sentence": "These results are in good agreement with those from Abbas et al. [44] obtained in chicken and Goff et al. [13] and Smith et al. [14] obtained in mice.",
            "startOffset": 40898,
            "title": "Discussion"
        },
        {
            "endOffset": 20002,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "sec0025",
            "sentence": "Cells were infected with the recombinant baculoviruses at a multiplicity of infection of approximately 5 and culture supernatant was harvested 4 days post infection by low-speed centrifugation (3.000 rpm, 10 min).",
            "startOffset": 19789,
            "title": "Production of virus-like particles in insect cells"
        },
        {
            "endOffset": 38518,
            "parents": [],
            "secId": "sec0085",
            "sentence": "We tended to address the importance of the cytotoxic immune response mediated by CD8+-cells in our challenge experiment.",
            "startOffset": 38398,
            "title": "Discussion"
        },
        {
            "endOffset": 29106,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "sec0060",
            "sentence": "Sera from all groups were assayed individually for the challenge strain PR8:SH1 for HI activity.",
            "startOffset": 29010,
            "title": "Hemagglutination inhibition assay"
        },
        {
            "endOffset": 20427,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Materials and methods"
                }
            ],
            "refoffsets": {
                "bib0115": {
                    "endOffset": 20426,
                    "startOffset": 20422
                }
            },
            "secId": "sec0030",
            "sentence": "To quantify the HA content of the VLPs, different concentrations of VLP samples were compared to known concentrations of recombinant His-tag purified SH1-HA containing a T4 foldon trimerisation domain [23].",
            "startOffset": 20221,
            "title": "Western blot analysis and HA quantification"
        },
        {
            "endOffset": 41163,
            "parents": [],
            "secId": "sec0085",
            "sentence": "We detected lower HI-activity for the PR8:SH1 virus than for PR8:AH1, even for the groups immunised with SH1-VLPs.",
            "startOffset": 41049,
            "title": "Discussion"
        },
        {
            "endOffset": 27530,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "sec0055",
            "sentence": "Following three washes with 100 \u03bcL PBST, plates were incubated with horseradish-peroxidase-conjugated anti-mouse IgG (Santa Cruz Biotechnology, Dallas, TX) at a dilution of 1:3000 in PBST and non-fat dry milk (1%, v/v) for 1 h at room temperature.",
            "startOffset": 27283,
            "title": "ELISA assays"
        },
        {
            "endOffset": 42122,
            "parents": [],
            "secId": "sec0090",
            "sentence": "Here we show full protection of mice vaccinated with low doses of an H7-VLP vaccine based on the HA antigens of the novel H7N9 strains in a one-shot vaccination strategy from a stringent lethal challenge with an H7N9 virus.",
            "startOffset": 41899,
            "title": "Conclusion"
        },
        {
            "endOffset": 33900,
            "parents": [
                {
                    "id": "sec0065",
                    "title": "Results"
                }
            ],
            "secId": "sec0080",
            "sentence": "Results show that the VLP-based H7 vaccine induced high HI-active antibody titres up to 1:40 for PR8:SH1 and up to 1:80 against PR8:AH1 (Table 1).",
            "startOffset": 33754,
            "title": "H7 VLPs induce cross-reactive HI active antibody responses"
        },
        {
            "endOffset": 34604,
            "parents": [
                {
                    "id": "sec0065",
                    "title": "Results"
                }
            ],
            "secId": "sec0080",
            "sentence": "No HI antibodies were detected in the two control groups (na\u00efve and M1-vaccinated mice).",
            "startOffset": 34516,
            "title": "H7 VLPs induce cross-reactive HI active antibody responses"
        },
        {
            "endOffset": 34372,
            "parents": [
                {
                    "id": "sec0065",
                    "title": "Results"
                }
            ],
            "secId": "sec0080",
            "sentence": "Single vaccination with the two higher SH1-VLP vaccine doses (3 \u03bcg and 0.3 \u03bcg) generated similar amounts of HI-active antibodies for all tested virus strains and negligible HI titres were measured for the lowest vaccine dose (0.03 \u03bcg).",
            "startOffset": 34137,
            "title": "H7 VLPs induce cross-reactive HI active antibody responses"
        },
        {
            "endOffset": 36476,
            "parents": [],
            "refoffsets": {
                "bib0180": {
                    "endOffset": 36475,
                    "startOffset": 36471
                }
            },
            "secId": "sec0085",
            "sentence": "Based on predictions that consider the current maximum global capacity for influenza virus vaccine manufacturing vaccine production will be too slow to adequately meet the needs for a vaccine in the event of a pandemic [36].",
            "startOffset": 36252,
            "title": "Discussion"
        },
        {
            "endOffset": 25640,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "sec0050",
            "sentence": "Three weeks after the last immunisation blood was drawn from anesthetised mice by submandibular bleeding.",
            "startOffset": 25535,
            "title": "Mouse immunisation and challenge"
        },
        {
            "endOffset": 25992,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "sec0055",
            "sentence": "A quantitative ELISA was performed to assess titres of HA-specific IgG.",
            "startOffset": 25921,
            "title": "ELISA assays"
        },
        {
            "endOffset": 35982,
            "parents": [],
            "refoffsets": {
                "bib0170": {
                    "endOffset": 35981,
                    "startOffset": 35974
                },
                "bib0175": {
                    "endOffset": 35981,
                    "startOffset": 35974
                }
            },
            "secId": "sec0085",
            "sentence": "However, most H7 vaccines showed low immunogenicity in humans and might not be able to raise titres of HI-active antibodies in the protective range [34,35].",
            "startOffset": 35826,
            "title": "Discussion"
        },
        {
            "endOffset": 39594,
            "parents": [],
            "refoffsets": {
                "bib0080": {
                    "endOffset": 39422,
                    "startOffset": 39415
                },
                "bib0130": {
                    "endOffset": 39527,
                    "startOffset": 39523
                },
                "bib0205": {
                    "endOffset": 39422,
                    "startOffset": 39415
                }
            },
            "secId": "sec0085",
            "sentence": "As the delivery route of VLPs was shown to influence the strengths of the humoral and cellular immune response [16,41], one might speculate whether the survival rate would have been higher in the study of Hemann et al. [26], if an alternative to the intranasal vaccination route was chosen.",
            "startOffset": 39304,
            "title": "Discussion"
        },
        {
            "endOffset": 42632,
            "parents": [],
            "secId": "sec0090",
            "sentence": "We would assume that they play a substantial role in the efficacy and potent immunogenicity of the H7 VLP vaccine tested here.",
            "startOffset": 42506,
            "title": "Conclusion"
        },
        {
            "endOffset": 35825,
            "parents": [],
            "refoffsets": {
                "bib0040": {
                    "endOffset": 35786,
                    "startOffset": 35768
                },
                "bib0045": {
                    "endOffset": 35786,
                    "startOffset": 35768
                },
                "bib0050": {
                    "endOffset": 35786,
                    "startOffset": 35768
                },
                "bib0055": {
                    "endOffset": 35786,
                    "startOffset": 35768
                },
                "bib0060": {
                    "endOffset": 35824,
                    "startOffset": 35814
                },
                "bib0065": {
                    "endOffset": 35786,
                    "startOffset": 35768
                },
                "bib0070": {
                    "endOffset": 35786,
                    "startOffset": 35768
                },
                "bib0155": {
                    "endOffset": 35786,
                    "startOffset": 35768
                },
                "bib0160": {
                    "endOffset": 35786,
                    "startOffset": 35768
                },
                "bib0165": {
                    "endOffset": 35824,
                    "startOffset": 35814
                },
                "bib0170": {
                    "endOffset": 35824,
                    "startOffset": 35814
                },
                "bib0175": {
                    "endOffset": 35824,
                    "startOffset": 35814
                }
            },
            "secId": "sec0085",
            "sentence": "Human H7 vaccines are underway and have been evaluated in preclinical [8\u201311,13,14,31,32] or phase I or I/II studies [12,33\u201335].",
            "startOffset": 35698,
            "title": "Discussion"
        },
        {
            "endOffset": 43490,
            "parents": [],
            "refoffsets": {
                "bib0225": {
                    "endOffset": 43489,
                    "startOffset": 43482
                },
                "bib0230": {
                    "endOffset": 43489,
                    "startOffset": 43482
                }
            },
            "secId": "sec0090",
            "sentence": "Assessment of the latter ratio might be difficult due to the presence of baculovirus\u2013VLP hybrids \u2013 baculovirus particles that incorporate HA and VLPs that incorporate baculovirus capsid and envelope proteins [45,46].",
            "startOffset": 43274,
            "title": "Conclusion"
        },
        {
            "endOffset": 39197,
            "parents": [],
            "secId": "sec0085",
            "sentence": "This suggests that our VLP preparation induces sufficiently high titres of neutralising antibodies, even at low single vaccine doses of 0.03\u20130.3 \u03bcg VLP, to be protective in a stringent homologous and heterologous challenge.",
            "startOffset": 38974,
            "title": "Discussion"
        },
        {
            "endOffset": 41888,
            "parents": [],
            "secId": "sec0085",
            "sentence": "It is of note that even the group that received the lowest VLP dose of 0.03 \u03bcg and had only neglectable HI-activity was completely protected from challenge, suggesting that detectable levels of HI-active antibodies might not be required for protection.",
            "startOffset": 41636,
            "title": "Discussion"
        },
        {
            "endOffset": 35209,
            "parents": [],
            "secId": "sec0085",
            "sentence": "Limited reports on new human incidences might be due to the shutdown of live poultry markets throughout the country.",
            "startOffset": 35093,
            "title": "Discussion"
        },
        {
            "endOffset": 40699,
            "parents": [],
            "secId": "sec0085",
            "sentence": "We therefore investigated the activity of the elicited antibodies by a hemagglutination inhibition assay with a panel of H7 strains.",
            "startOffset": 40567,
            "title": "Discussion"
        },
        {
            "endOffset": 39303,
            "parents": [],
            "secId": "sec0085",
            "sentence": "A contribution of virus-specific CD8+-cells to protection from infection might be redundant in this case.",
            "startOffset": 39198,
            "title": "Discussion"
        },
        {
            "endOffset": 14583,
            "parents": [],
            "refoffsets": {
                "bib0010": {
                    "endOffset": 14454,
                    "startOffset": 14449
                },
                "bib0020": {
                    "endOffset": 14454,
                    "startOffset": 14449
                },
                "bib0025": {
                    "endOffset": 14582,
                    "startOffset": 14579
                }
            },
            "secId": "sec0005",
            "sentence": "Since the novel H7N9 strains are resistant to M2 ion channel blockers [2,4], neuraminidase inhibitors are recommended as frontline therapeutic by the Chinese Center for Disease Control and Prevention [5].",
            "startOffset": 14379,
            "title": "Introduction"
        },
        {
            "endOffset": 40372,
            "parents": [],
            "refoffsets": {
                "bib0110": {
                    "endOffset": 40371,
                    "startOffset": 40364
                },
                "bib0215": {
                    "endOffset": 40371,
                    "startOffset": 40364
                }
            },
            "secId": "sec0085",
            "sentence": "It was previously shown that vaccination with different immunogens that vary only in their globular head region, specifically could boost the stalk-reactive antibody response in mice [22,43].",
            "startOffset": 40181,
            "title": "Discussion"
        },
        {
            "endOffset": 20175,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "sec0025",
            "sentence": "VLPs were partially purified and concentrated using a 30% (w/v) sucrose cushion in phosphate buffered saline (PBS) and the pellet was resuspended in PBS and stored at 4 \u00b0C.",
            "startOffset": 20003,
            "title": "Production of virus-like particles in insect cells"
        },
        {
            "endOffset": 41482,
            "parents": [],
            "secId": "sec0085",
            "sentence": "The second immunisation leads to a two-fold increase in HI titres for almost all tested virus strains.",
            "startOffset": 41380,
            "title": "Discussion"
        },
        {
            "endOffset": 13694,
            "parents": [],
            "refoffsets": {
                "bib0005": {
                    "endOffset": 13693,
                    "startOffset": 13690
                }
            },
            "secId": "sec0005",
            "sentence": "On March 31, 2013 the Chinese public health authorities reported three cases of laboratory-confirmed human infection with a novel avian-origin influenza A H7N9 virus [1].",
            "startOffset": 13524,
            "title": "Introduction"
        },
        {
            "endOffset": 18042,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "sec0020",
            "sentence": "SH1 and AH1 HA and NA sequences were subcloned into the ambisense rescue plasmid pDZ for rescue of recombinant influenza viruses.",
            "startOffset": 17913,
            "title": "Viruses"
        },
        {
            "endOffset": 32752,
            "parents": [
                {
                    "id": "sec0065",
                    "title": "Results"
                }
            ],
            "refoffsets": {
                "bib0065": {
                    "endOffset": 32528,
                    "startOffset": 32521
                },
                "bib0140": {
                    "endOffset": 32528,
                    "startOffset": 32521
                }
            },
            "secId": "sec0075",
            "sentence": "As previous studies reported a remarkable cross-reactivity of H7 antibodies [13,28], we tested sero-reactivity to a panel of divergent recombinant H7 proteins and a representative HA from each influenza subtype (H3, H4, H10, H14 and H15 \u2013 in addition to H7) that cluster into phylogenetic group 2 (Fig. 2A).",
            "startOffset": 32445,
            "title": "H7 VLP vaccines induce broadly reactive antibodies"
        },
        {
            "endOffset": 41635,
            "parents": [],
            "refoffsets": {
                "bib0065": {
                    "endOffset": 41634,
                    "startOffset": 41630
                }
            },
            "secId": "sec0085",
            "sentence": "The observed HI crossreactivity might be the result of the completely conserved antigenic site A of Eurasian and North American lineage H7 viruses [13].",
            "startOffset": 41483,
            "title": "Discussion"
        },
        {
            "endOffset": 23940,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "sec0045",
            "sentence": "The content of infectious baculovirus per \u03bcg HA varied slightly between 1.03 \u00d7 107 and 2.62 \u00d7 107 pfu (plaque forming units).",
            "startOffset": 23815,
            "title": "Vaccine formulation"
        },
        {
            "endOffset": 24209,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "sec0045",
            "sentence": "For further characterisation the migration pattern of the VLPs into a sucrose gradient was analysed by ultracentrifugation (Suppl. Fig. 1).",
            "startOffset": 24070,
            "title": "Vaccine formulation"
        },
        {
            "endOffset": 15461,
            "parents": [],
            "secId": "sec0005",
            "sentence": "Two-component influenza virus-like particles, containing HAs from the first H7N9 virus isolates (A/Anhui/1/13 or A/Shanghai/1/13, respectively) and the matrix protein (M1) from A/Udorn/307/1972, were produced in the Trichoplusia ni insect cell line High Five (BTI-TN-5B1-4) using the baculovirus expression system.",
            "startOffset": 15147,
            "title": "Introduction"
        },
        {
            "endOffset": 27282,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "sec0055",
            "sentence": "Plates were incubated with 3-fold dilutions to endpoint titre of pooled serum samples (100 \u03bcL per well in PBST with 1% non-fat dry milk (starting concentration: 1:50 dilution) for 2 h at room temperature.",
            "startOffset": 27078,
            "title": "ELISA assays"
        },
        {
            "endOffset": 25197,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "sec0050",
            "sentence": "A control group (N = 5) was immunised once with M1-only VLPs at a total protein concentration equal to that of the SH1-0.3 \u03bcg vaccine dose.",
            "startOffset": 25058,
            "title": "Mouse immunisation and challenge"
        },
        {
            "endOffset": 28876,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "sec0060",
            "sentence": "Serum samples were 2-fold serially diluted in PBS (25 \u03bcL sample volume) in Nunc\u00ae 96-well polystyrene V-bottom microwell plates (Thermo Fisher Scientific, Waltham, MA) and then incubated with recombinant reassortant virus (PR8:AH1, PR8:SH1, PR8:malNL00, PR8:malAlb01 or PR8:chickJal12) at 4 HAU/25 \u03bcL in PBS for 30 min at room temperature.",
            "startOffset": 28538,
            "title": "Hemagglutination inhibition assay"
        },
        {
            "endOffset": 29009,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "sec0060",
            "sentence": "Then, 50 \u03bcL 0.5% tRBCs (Lampire Biological Laboratory, Pipersville, PA) were added and the mixture was incubated for 45 min at 4 \u00b0C.",
            "startOffset": 28877,
            "title": "Hemagglutination inhibition assay"
        },
        {
            "endOffset": 32899,
            "parents": [
                {
                    "id": "sec0065",
                    "title": "Results"
                }
            ],
            "secId": "sec0075",
            "sentence": "Strong sero-reactivity was detected against the HA of the vaccine strains SH1 and AH1.",
            "startOffset": 32813,
            "title": "H7 VLP vaccines induce broadly reactive antibodies"
        },
        {
            "endOffset": 33158,
            "parents": [
                {
                    "id": "sec0065",
                    "title": "Results"
                }
            ],
            "secId": "sec0075",
            "sentence": "Other representative strains of the Eurasian lineage (malNL00) and more divergent H7 strains from the North American lineage (rheaNC99, chickJal12) showed endpoint titres only up to 3-fold lower than were achieved with the HA of the vaccine strain (Fig. 2B).",
            "startOffset": 32900,
            "title": "H7 VLP vaccines induce broadly reactive antibodies"
        },
        {
            "endOffset": 36605,
            "parents": [],
            "secId": "sec0085",
            "sentence": "A major factor limiting the manufacturing capacity of a vaccine is the minimum immunogenic antigen dose that confers protection.",
            "startOffset": 36477,
            "title": "Discussion"
        },
        {
            "endOffset": 14378,
            "parents": [],
            "secId": "sec0005",
            "sentence": "Antivirals are currently the only prophylactic and therapeutic options available for human use.",
            "startOffset": 14283,
            "title": "Introduction"
        },
        {
            "endOffset": 30708,
            "parents": [
                {
                    "id": "sec0065",
                    "title": "Results"
                }
            ],
            "secId": "sec0070",
            "sentence": "We also compared groups that received a single vaccine dose with a group that received two immunisations on days 0 and 14 (0.3 \u03bcg in terms of HA content).",
            "startOffset": 30554,
            "title": "Efficacy of H7-VLPs in an in vivo mouse challenge experiment"
        },
        {
            "endOffset": 42939,
            "parents": [],
            "secId": "sec0090",
            "sentence": "However, bioactive, live viruses in vaccine formulations might induce strong reactogenicity and safety concerns might prevent their application in humans.",
            "startOffset": 42785,
            "title": "Conclusion"
        },
        {
            "endOffset": 30553,
            "parents": [
                {
                    "id": "sec0065",
                    "title": "Results"
                }
            ],
            "secId": "sec0070",
            "sentence": "We assessed protection conferred by three different concentrations of SH1-VLPs (3 \u03bcg, 0.3 \u03bcg and 0.03 \u03bcg in terms of HA content, administered intramuscularly).",
            "startOffset": 30394,
            "title": "Efficacy of H7-VLPs in an in vivo mouse challenge experiment"
        },
        {
            "endOffset": 22252,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "sec0035",
            "sentence": "RBCs were allowed to settle for 45\u201360 min at 4 \u00b0C and the HA titre was determined by visual inspection.",
            "startOffset": 22149,
            "title": "Hemagglutination assay"
        },
        {
            "endOffset": 23317,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "sec0040",
            "sentence": "The plates were incubated at 27 \u00b0C for 6 days and plaques were counted after live-cell staining with 200 \u03bcL of 5 mg/mL Thiazolyl blue formazan MTT (Sigma, St. Louis, MO) for 3\u20134 h.",
            "startOffset": 23137,
            "title": "Quantification of baculovirus content in the vaccine preparation"
        },
        {
            "endOffset": 32392,
            "parents": [
                {
                    "id": "sec0065",
                    "title": "Results"
                }
            ],
            "secId": "sec0070",
            "sentence": "Minimal weight loss for CD8+-depleted, SH1-0.3 \u03bcg-vaccinated mice after challenge and a 100% survival rate (Fig. 1B and D) suggested that the humoral response was sufficient to robustly protect these animals.",
            "startOffset": 32184,
            "title": "Efficacy of H7-VLPs in an in vivo mouse challenge experiment"
        },
        {
            "endOffset": 34136,
            "parents": [
                {
                    "id": "sec0065",
                    "title": "Results"
                }
            ],
            "secId": "sec0080",
            "sentence": "Both VLP vaccines were also able to induce levels of HI antibodies that prevented virus-induced hemagglutination by a panel of divergent H7 strains of the Eurasian and the more distant North American lineage, with titres of up to 1:40.",
            "startOffset": 33901,
            "title": "H7 VLPs induce cross-reactive HI active antibody responses"
        },
        {
            "endOffset": 40566,
            "parents": [],
            "secId": "sec0085",
            "sentence": "However, both our immunisations for the prime-boost group were performed with the same immunogen and we assume that the boost in sero-reactivity primarily results from head-specific antibodies.",
            "startOffset": 40373,
            "title": "Discussion"
        },
        {
            "endOffset": 42784,
            "parents": [],
            "secId": "sec0090",
            "sentence": "VLP vaccines that contain baculoviruses might prove to be useful in pandemic situations where large quantities of highly effective vaccines are needed.",
            "startOffset": 42633,
            "title": "Conclusion"
        },
        {
            "endOffset": 24069,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "sec0045",
            "sentence": "All vaccine doses including the M1-only VLP negative control contained similar doses of infectious baculovirus (Suppl. Table 1).",
            "startOffset": 23941,
            "title": "Vaccine formulation"
        },
        {
            "endOffset": 37461,
            "parents": [],
            "refoffsets": {
                "bib0070": {
                    "endOffset": 37460,
                    "startOffset": 37456
                }
            },
            "secId": "sec0085",
            "sentence": "This is in contrast to an earlier study by Smith et al. who reported that mice vaccinated with a two dose regimen with 0.7\u20132 \u03bcg lost 10\u201315% of their initial body weight after a 3.5 LD50 challenge [14].",
            "startOffset": 37260,
            "title": "Discussion"
        },
        {
            "endOffset": 17345,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Materials and methods"
                }
            ],
            "refoffsets": {
                "bib0085": {
                    "endOffset": 17107,
                    "startOffset": 17103
                },
                "bib0090": {
                    "endOffset": 17283,
                    "startOffset": 17279
                }
            },
            "secId": "sec0015",
            "sentence": "BTI-TN-5B1-4 (High Five \u2013 Vienna Institute of Biotechnology subclone) [17] cells were used for expression of VLPs and maintained at 27 \u00b0C in custom modified serum-free IPL-41 medium (PAN-Biotech GmbH, Aidenbach, Germany) at 27 \u00b0C as described in [18] supplemented with Penicillin\u2013Streptomycin antibiotic mixture.",
            "startOffset": 17033,
            "title": "Insect cells"
        },
        {
            "endOffset": 39764,
            "parents": [],
            "refoffsets": {
                "bib0065": {
                    "endOffset": 39763,
                    "startOffset": 39759
                }
            },
            "secId": "sec0085",
            "sentence": "Single immunisations with our vaccine could induce antibodies that were reactive to all heterologous H7 subtypes tested (Fig. 2), in agreement with an earlier study [13].",
            "startOffset": 39594,
            "title": "Discussion"
        },
        {
            "endOffset": 20542,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "sec0030",
            "sentence": "VLP and His-tag HA were separated by SDS-PAGE using 4\u201312% gradient polyacrylamide gels (Invitrogen, Carlsbad, CA).",
            "startOffset": 20428,
            "title": "Western blot analysis and HA quantification"
        },
        {
            "endOffset": 28012,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "sec0055",
            "sentence": "The endpoint titre was defined as the reciprocal of the highest dilution that yields an OD-value above the mean plus three standard deviations of blank wells.",
            "startOffset": 27854,
            "title": "ELISA assays"
        },
        {
            "endOffset": 36963,
            "parents": [],
            "secId": "sec0085",
            "sentence": "Here, we chose to evaluate a low-dose single-shot VLP vaccine against the novel H7N9 virus.",
            "startOffset": 36872,
            "title": "Discussion"
        },
        {
            "endOffset": 42505,
            "parents": [],
            "refoffsets": {
                "bib0080": {
                    "endOffset": 42504,
                    "startOffset": 42500
                }
            },
            "secId": "sec0090",
            "sentence": "We have previously shown that the presence of active baculovirus in insect cell-derived VLP preparation is able to substantially increase immunogenicity and protection due to its immune-stimulatory capability [16].",
            "startOffset": 42291,
            "title": "Conclusion"
        },
        {
            "endOffset": 29519,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "sec0060",
            "sentence": "Two negative HI readings were assigned <10, single negative results were scored a value of 5 for the calculation of geometric means.",
            "startOffset": 29387,
            "title": "Hemagglutination inhibition assay"
        },
        {
            "endOffset": 19366,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Materials and methods"
                }
            ],
            "refoffsets": {
                "bib0085": {
                    "endOffset": 19365,
                    "startOffset": 19361
                }
            },
            "secId": "sec0025",
            "sentence": "VLPs consisting of the respective H7 HA (either AH1 or SH1) and the matrix protein (M1) from the unrelated H3N2 subtype were produced by baculovirus infection of insect cells as described before [17].",
            "startOffset": 19166,
            "title": "Production of virus-like particles in insect cells"
        },
        {
            "endOffset": 21468,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "sec0030",
            "sentence": "Then, membranes were rinsed again and protein bands were visualised using the two-component Western Lightning\u00ae Plus-ECL enhanced chemiluminescence substrate kit (PerkinElmer, Inc., Waltham, MA) and Ultra Cruz\u2122 Autoradiography Blue Films (Santa Cruz Biotechnology, Inc., Dallas, TX).",
            "startOffset": 21186,
            "title": "Western blot analysis and HA quantification"
        },
        {
            "endOffset": 27077,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "sec0055",
            "sentence": "Plates were blocked with PBST and 3% (w/v) non-fat dry milk for 2 h at room temperature.",
            "startOffset": 26989,
            "title": "ELISA assays"
        },
        {
            "endOffset": 35549,
            "parents": [],
            "refoffsets": {
                "bib0030": {
                    "endOffset": 35548,
                    "startOffset": 35543
                },
                "bib0035": {
                    "endOffset": 35548,
                    "startOffset": 35543
                }
            },
            "secId": "sec0085",
            "sentence": "Since no vaccine for H7N9 is available for humans, antivirals are the only treatment options, but bear the risk to yield treatment-resistant viruses, which were already associated with poor clinical outcome [6,7].",
            "startOffset": 35336,
            "title": "Discussion"
        },
        {
            "endOffset": 30145,
            "parents": [
                {
                    "id": "sec0065",
                    "title": "Results"
                }
            ],
            "refoffsets": {
                "bib0080": {
                    "endOffset": 29921,
                    "startOffset": 29917
                }
            },
            "secId": "sec0070",
            "sentence": "In a previous study by Margine and colleagues [16] showed that residual baculovirus in VLP formulations enhance the immunogenicity of the vaccine due to potent stimulation of the innate immune response and by biasing IgG isotype distribution to the more active IgG2 subtype.",
            "startOffset": 29871,
            "title": "Efficacy of H7-VLPs in an in vivo mouse challenge experiment"
        },
        {
            "endOffset": 15993,
            "parents": [],
            "secId": "sec0005",
            "sentence": "Mice received one VLP vaccine dose containing different amounts of HA (3 \u03bcg, 0.3 \u03bcg and 0.03 \u03bcg) and 5 weeks later were challenged with a stringent viral dose (100 mLD50) of the A/Shanghai/1/13 H7N9 strain.",
            "startOffset": 15787,
            "title": "Introduction"
        },
        {
            "endOffset": 26077,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "sec0055",
            "sentence": "Sera (N = 5) from the different vaccine groups were pooled and assayed in duplicate.",
            "startOffset": 25993,
            "title": "ELISA assays"
        },
        {
            "endOffset": 14149,
            "parents": [],
            "secId": "sec0005",
            "sentence": "This is the highest mortality number attributed to H7 infections worldwide to date.",
            "startOffset": 14066,
            "title": "Introduction"
        },
        {
            "endOffset": 28207,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "sec0060",
            "sentence": "The hemagglutination inhibition (HI) assay was used to assess functional antibodies to the HA able to inhibit agglutination of turkey red blood cells (tRBCs).",
            "startOffset": 28049,
            "title": "Hemagglutination inhibition assay"
        },
        {
            "endOffset": 17448,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Materials and methods"
                }
            ],
            "refoffsets": {
                "bib0095": {
                    "endOffset": 17447,
                    "startOffset": 17440
                },
                "bib0100": {
                    "endOffset": 17447,
                    "startOffset": 17440
                },
                "bib0105": {
                    "endOffset": 17447,
                    "startOffset": 17440
                }
            },
            "secId": "sec0020",
            "sentence": "Recombinant influenza viruses were generated by reverse genetics as described before [19\u201321].",
            "startOffset": 17355,
            "title": "Viruses"
        },
        {
            "endOffset": 25057,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "sec0050",
            "sentence": "The prime-boost group (N = 5) was immunised twice with 0.3 \u03bcg SH1-VLPs, at an interval of 14 days.",
            "startOffset": 24959,
            "title": "Mouse immunisation and challenge"
        },
        {
            "endOffset": 32183,
            "parents": [
                {
                    "id": "sec0065",
                    "title": "Results"
                }
            ],
            "refoffsets": {
                "bib0130": {
                    "endOffset": 32072,
                    "startOffset": 32065
                },
                "bib0135": {
                    "endOffset": 32072,
                    "startOffset": 32065
                }
            },
            "secId": "sec0070",
            "sentence": "Since previous studies highlight the critical role of CD8+ T-cells in protective immunity to influenza infection [26,27], we assessed whether a single low vaccine dose could also induce full protection in CD8+ T-cell-depleted mice.",
            "startOffset": 31952,
            "title": "Efficacy of H7-VLPs in an in vivo mouse challenge experiment"
        },
        {
            "endOffset": 25453,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Materials and methods"
                }
            ],
            "refoffsets": {
                "bib0125": {
                    "endOffset": 25368,
                    "startOffset": 25364
                }
            },
            "secId": "sec0050",
            "sentence": "CD8+-depleted prime-only groups received one immunisation with 0.3 \u03bcg SH1- or M1-VLPs (N = 5) and were treated by IP injection of 300 \u03bcg of anti-CD8+ T-cell antibody [25] (from hybridoma line 2.43) for CD8+ T-cell depletion 48 and 24 h prior to challenge.",
            "startOffset": 25198,
            "title": "Mouse immunisation and challenge"
        },
        {
            "endOffset": 17912,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "sec0020",
            "sentence": "Gene synthesis was conducted by GeneArt (Life Technologies, Carlsbad, CA).",
            "startOffset": 17838,
            "title": "Viruses"
        },
        {
            "endOffset": 31096,
            "parents": [
                {
                    "id": "sec0065",
                    "title": "Results"
                }
            ],
            "secId": "sec0070",
            "sentence": "Similarly, no weight loss was observed for the SH1-3 \u03bcg prime-only group.",
            "startOffset": 31023,
            "title": "Efficacy of H7-VLPs in an in vivo mouse challenge experiment"
        },
        {
            "endOffset": 34879,
            "parents": [],
            "refoffsets": {
                "bib0005": {
                    "endOffset": 34777,
                    "startOffset": 34774
                }
            },
            "secId": "sec0085",
            "sentence": "On 31 March 2013, the Chinese Health and Family Planning Commission notified the WHO of three cases of human infections with a novel influenza A (H7N9) strain [1], which has been the causative agent for 137 infections with a mortality rate of 33% as of 25 October.",
            "startOffset": 34615,
            "title": "Discussion"
        },
        {
            "endOffset": 43090,
            "parents": [],
            "secId": "sec0090",
            "sentence": "Importantly, a bioactive baculovirus component of a vaccine would need to be standardised and tested for stability under different storage conditions.",
            "startOffset": 42940,
            "title": "Conclusion"
        },
        {
            "endOffset": 19707,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "sec0025",
            "sentence": "Recombinant baculovirus was rescued from Sf9 cells and amplified.",
            "startOffset": 19642,
            "title": "Production of virus-like particles in insect cells"
        },
        {
            "endOffset": 22918,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "sec0040",
            "sentence": "After seeding 1 \u00d7 106 cells per well, the cells were allowed to attach to the surface, medium was removed and 200 \u03bcL of the diluted VLP vaccine formulations (10-fold dilutions in TNM-FH unsupplemented) were added and incubated for 1 h at 27 \u00b0C with periodic shaking.",
            "startOffset": 22652,
            "title": "Quantification of baculovirus content in the vaccine preparation"
        },
        {
            "endOffset": 25534,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "sec0050",
            "sentence": "Naive mice (N = 5 per group) were included as additional negative control group.",
            "startOffset": 25454,
            "title": "Mouse immunisation and challenge"
        },
        {
            "endOffset": 24478,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "sec0050",
            "sentence": "Animal experiments were performed using 6\u20138 week-old female BALB/c mice (Jackson Laboratories) according to the guidelines of the Icahn School of Medicine at Mount Sinai Institutional Animal Care and Use Committee (permit LA12-00028).",
            "startOffset": 24244,
            "title": "Mouse immunisation and challenge"
        },
        {
            "endOffset": 23478,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "sec0045",
            "sentence": "SH1-VLPs were prepared in three different concentrations in PBS as per HA content (3 \u03bcg, 0.3 \u03bcg and 0.03 \u03bcg SH1-HA per 50 \u03bcL vaccine dose).",
            "startOffset": 23339,
            "title": "Vaccine formulation"
        },
        {
            "endOffset": 17032,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "sec0015",
            "sentence": "For baculovirus amplification, the medium was switched to 3% (v/v) FBS.",
            "startOffset": 16961,
            "title": "Insect cells"
        },
        {
            "endOffset": 39925,
            "parents": [],
            "secId": "sec0085",
            "sentence": "We could also demonstrate significant reactivity to other members of group 2 HAs, such as the phylogenetically related H15 subtype and the more divergent H3 HA.",
            "startOffset": 39765,
            "title": "Discussion"
        },
        {
            "endOffset": 16960,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "sec0015",
            "sentence": "Sf9 insect cells (ATCC # CRL-1711) were routinely propagated at 27 \u00b0C in TNM-FH medium (Gemini Bio-Products, West Sacramento, CA) supplemented with 0.1% (v/v) Pluronic 68 (Sigma, St. Louis, MO), 10% (v/v) foetal bovine serum (FBS) (Atlanta Biologicals, Norcross, GA) and Penicillin\u2013Streptomycin antibiotic mixture (Life Technologies, Carlsbad, CA).",
            "startOffset": 16612,
            "title": "Insect cells"
        },
        {
            "endOffset": 18325,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "sec0020",
            "sentence": "Additional recombinant PR8 virus (7:1) were generated that expressed the HA of the H7 Eurasian lineage virus A/mallard/NL/12/00 (H7N3; PR8:malNL00), or the HA of A/chicken/Jalisco/12283/12 (H7N3; PR8:chickJal12) which was genetically modified to remove the multibasic cleavage site.",
            "startOffset": 18043,
            "title": "Viruses"
        },
        {
            "endOffset": 26758,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Materials and methods"
                }
            ],
            "refoffsets": {
                "bib0115": {
                    "endOffset": 26269,
                    "startOffset": 26265
                }
            },
            "secId": "sec0055",
            "sentence": "HA proteins of representatives of all influenza A group 2 subtypes were recombinantly expressed with a C-terminal T4 foldon trimerisation domain and an N-terminal His-tag as described in [23] and used as antigens (HAs from A/Shanghai/1/13 (H7N9, abbreviated SH1), A/Anhui/1/13 (H7N9, AH1), A/mallard/NL/12/00 (H7N3, malNL00), A/rhea/North Carolina/39482/93 (H7N1, rheaNC93), A/chicken/Jalisco/12283/12 (H7N3, chickJal12), A/Hong Kong/1/68 (H3N2, H3), A/duck/Czech/56 (H4N6, H4), A/mallard/Interior Alaska/10BM01929/10 (H10N7, H10), A/mallard/Gurjev/263/82 (H14N5, H14), A/wedge tailed shearwater/Western Australia/2576/79 (H15N9, H15) and A/California/04/09 (pandemic H1N1, pH1)).",
            "startOffset": 26078,
            "title": "ELISA assays"
        },
        {
            "endOffset": 29870,
            "parents": [
                {
                    "id": "sec0065",
                    "title": "Results"
                }
            ],
            "secId": "sec0070",
            "sentence": "In preparedness for a potential H7N9 pandemic, it is highly desirable, not only for vaccine manufacturers, but also for health care providers, to develop an influenza vaccine that at low vaccine dose, most preferably with a single administration, stimulates good immune responses.",
            "startOffset": 29590,
            "title": "Efficacy of H7-VLPs in an in vivo mouse challenge experiment"
        },
        {
            "endOffset": 42185,
            "parents": [],
            "secId": "sec0090",
            "sentence": "Furthermore, these VLPs induced broad sero- and HI-reactivity.",
            "startOffset": 42123,
            "title": "Conclusion"
        },
        {
            "endOffset": 20941,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "sec0030",
            "sentence": "After three washes with PBST, the blots were incubated for 3 h with convalescent serum obtained from mice sublethally infected with SH1 at a dilution of 1:1000.",
            "startOffset": 20781,
            "title": "Western blot analysis and HA quantification"
        },
        {
            "endOffset": 22651,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "sec0040",
            "sentence": "Briefly, the assay was carried out in 6-well plates in duplicates.",
            "startOffset": 22585,
            "title": "Quantification of baculovirus content in the vaccine preparation"
        },
        {
            "endOffset": 37259,
            "parents": [],
            "secId": "sec0085",
            "sentence": "Mice that were vaccinated with a single vaccine dose of 3 \u03bcg SH1-VLP did not show any sign of disease.",
            "startOffset": 37157,
            "title": "Discussion"
        },
        {
            "endOffset": 30393,
            "parents": [
                {
                    "id": "sec0065",
                    "title": "Results"
                }
            ],
            "secId": "sec0070",
            "sentence": "Thus, we evaluated whether unadjuvanted single immunisations with low doses of our VLP-vaccine containing baculovirus were effective in eliciting protective immune responses in an in vivo mouse experiment using a stringent 100 mLD50 challenge dose.",
            "startOffset": 30145,
            "title": "Efficacy of H7-VLPs in an in vivo mouse challenge experiment"
        },
        {
            "endOffset": 34515,
            "parents": [
                {
                    "id": "sec0065",
                    "title": "Results"
                }
            ],
            "secId": "sec0080",
            "sentence": "The second dose of SH1-VLP vaccine led to a 2-fold enhancement of average levels of HI-active antibodies for most of the virus strains tested.",
            "startOffset": 34373,
            "title": "H7 VLPs induce cross-reactive HI active antibody responses"
        },
        {
            "endOffset": 13944,
            "parents": [],
            "refoffsets": {
                "bib0010": {
                    "endOffset": 13943,
                    "startOffset": 13940
                }
            },
            "secId": "sec0005",
            "sentence": "Two patients in Shanghai and one in the surrounding Anhui province were hospitalised with symptoms of cough, dyspnoea and high fever and developed acute respiratory distress syndrome (ARDS) and pneumonia complications, which proved to be deadly [2].",
            "startOffset": 13695,
            "title": "Introduction"
        },
        {
            "endOffset": 25906,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "sec0050",
            "sentence": "Weight loss was monitored daily for up to 14 days and animals that lost 25% or more of their initial body weight were scored dead and humanely euthanised, according to institutional guidelines.",
            "startOffset": 25713,
            "title": "Mouse immunisation and challenge"
        },
        {
            "endOffset": 35335,
            "parents": [],
            "refoffsets": {
                "bib0150": {
                    "endOffset": 35334,
                    "startOffset": 35330
                }
            },
            "secId": "sec0085",
            "sentence": "However, H7N9 may also follow a seasonal outbreak pattern similar to H5N1, therefore an epidemic could re-occur in fall [30].",
            "startOffset": 35210,
            "title": "Discussion"
        },
        {
            "endOffset": 42290,
            "parents": [],
            "secId": "sec0090",
            "sentence": "Based on this data we speculate that the vaccine could also protect against other, divergent H7 strains.",
            "startOffset": 42186,
            "title": "Conclusion"
        },
        {
            "endOffset": 14701,
            "parents": [],
            "refoffsets": {
                "bib0030": {
                    "endOffset": 14700,
                    "startOffset": 14695
                },
                "bib0035": {
                    "endOffset": 14700,
                    "startOffset": 14695
                }
            },
            "secId": "sec0005",
            "sentence": "However, oseltamivir-resistant viruses have been associated with antiviral treatment and poor clinical outcome [6,7].",
            "startOffset": 14584,
            "title": "Introduction"
        },
        {
            "endOffset": 28537,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "sec0060",
            "sentence": "After addition of 3 volumes of 2.5% (v/v) sodium citrate, the serum samples were incubated at 56 \u00b0C for 30 min and diluted with PBS to yield a 1:10 dilution of the original serum sample.",
            "startOffset": 28351,
            "title": "Hemagglutination inhibition assay"
        },
        {
            "endOffset": 37156,
            "parents": [],
            "secId": "sec0085",
            "sentence": "Single immunisation with as low as 0.03 \u03bcg SH1-VLP preparation (based on HA content) could confer full protection against a stringent homologous challenge (100 mLD50) in BALB/c mice (Fig. 1C).",
            "startOffset": 36964,
            "title": "Discussion"
        },
        {
            "endOffset": 19165,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Materials and methods"
                }
            ],
            "refoffsets": {
                "bib0085": {
                    "endOffset": 19164,
                    "startOffset": 19160
                }
            },
            "secId": "sec0025",
            "sentence": "Synthesised SH1 and AH1 HA genes (GISAID Epiflu database accession numbers EPI439486 and EPI439507, respectively) and the matrix protein (M1) gene from strain A/Udorn/307/72 (H3N2) (GenBank: DQ508932.1), synthesised by Sloning (Puchheim, Germany), were cloned as previously described [17].",
            "startOffset": 18876,
            "title": "Production of virus-like particles in insect cells"
        },
        {
            "endOffset": 31951,
            "parents": [
                {
                    "id": "sec0065",
                    "title": "Results"
                }
            ],
            "secId": "sec0070",
            "sentence": "This proves that neither M1 or the baculovirus or a combination of both was able to induce significant protective immune responses in our challenge model.",
            "startOffset": 31797,
            "title": "Efficacy of H7-VLPs in an in vivo mouse challenge experiment"
        },
        {
            "endOffset": 14065,
            "parents": [],
            "refoffsets": {
                "bib0015": {
                    "endOffset": 13971,
                    "startOffset": 13968
                }
            },
            "secId": "sec0005",
            "sentence": "As of October 25, 2013 [3], 137 human cases of influenza A H7N9 infection were reported to the WHO, including 45 deaths.",
            "startOffset": 13945,
            "title": "Introduction"
        },
        {
            "endOffset": 38397,
            "parents": [],
            "refoffsets": {
                "bib0130": {
                    "endOffset": 38396,
                    "startOffset": 38386
                },
                "bib0190": {
                    "endOffset": 38396,
                    "startOffset": 38386
                },
                "bib0195": {
                    "endOffset": 38396,
                    "startOffset": 38386
                }
            },
            "secId": "sec0085",
            "sentence": "Essentially, CD8+ T-cells play an important role in the clearance of virus infected cells and thereby limit viral replication, disease development and reduce mortality [26,38,39].",
            "startOffset": 38218,
            "title": "Discussion"
        },
        {
            "endOffset": 18567,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Materials and methods"
                }
            ],
            "refoffsets": {
                "bib0105": {
                    "endOffset": 18566,
                    "startOffset": 18559
                },
                "bib0110": {
                    "endOffset": 18566,
                    "startOffset": 18559
                }
            },
            "secId": "sec0020",
            "sentence": "An additional recombinant PR8 viruses was included that expressed a chimeric cH7/3 HA in which the globular head domain was derived from the H7 North American lineage virus A/mallard/Alberta/24/01 (H7N3; PR8:malAlb01) on an H3 stalk [21,22].",
            "startOffset": 18326,
            "title": "Viruses"
        },
        {
            "endOffset": 17837,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "sec0020",
            "sentence": "The nucleotide sequences of the HA and NA of SH1 and AH1 were downloaded from the GISAID Epiflu database (accession numbers EPI439486 and EPI439507, respectively).",
            "startOffset": 17674,
            "title": "Viruses"
        },
        {
            "endOffset": 33455,
            "parents": [
                {
                    "id": "sec0065",
                    "title": "Results"
                }
            ],
            "secId": "sec0075",
            "sentence": "Moreover, we could detect considerable cross-reactivity against subtypes H15 and H3 across all tested sera.",
            "startOffset": 33348,
            "title": "H7 VLP vaccines induce broadly reactive antibodies"
        },
        {
            "endOffset": 16476,
            "parents": [],
            "secId": "sec0005",
            "sentence": "In addition, a single vaccination with the H7 VLP vaccine induced serum antibodies that were broadly reactive and HI active against divergent H7 subtyped viruses.",
            "startOffset": 16314,
            "title": "Introduction"
        },
        {
            "endOffset": 29386,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "sec0060",
            "sentence": "The HI titre was calculated from the reciprocal of the highest dilution that completely inhibited hemagglutination of red blood cells and the geometric mean titre (GMT) of two independent assays was reported as the final titre.",
            "startOffset": 29159,
            "title": "Hemagglutination inhibition assay"
        },
        {
            "endOffset": 22584,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Materials and methods"
                }
            ],
            "refoffsets": {
                "bib0120": {
                    "endOffset": 22583,
                    "startOffset": 22579
                }
            },
            "secId": "sec0040",
            "sentence": "Baculovirus titres in the VLP vaccine doses were determined by plaque assay on Sf9 cells with minor modifications as described in [24].",
            "startOffset": 22449,
            "title": "Quantification of baculovirus content in the vaccine preparation"
        },
        {
            "endOffset": 24718,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "sec0050",
            "sentence": "Mice were anesthetised by intraperitoneal (IP) injection of 0.1 mL of a ketamine/xylazine mixture (0.15 mg/kg and 0.03 mg/kg) before intranasal procedures.",
            "startOffset": 24563,
            "title": "Mouse immunisation and challenge"
        },
        {
            "endOffset": 22148,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "sec0035",
            "sentence": "Two-fold serial dilutions of PR8:AH1, PR8:SH1, PR8:malNL00, PR8:malAlb01 and PR8:chickJal12 recombinant reassortant virus strains in PBS (50 \u03bcL) were prepared in Nunc\u00ae 96-well polystyrene V-bottom microwell plates (Thermo Fisher Scientific, Waltham, MA), followed by the addition of 50 \u03bcL 0.5% (v/v) chicken or turkey red blood cells (RBCs) (Lampire Biological Laboratory, Pipersville, PA) in PBS into each well.",
            "startOffset": 21736,
            "title": "Hemagglutination assay"
        },
        {
            "endOffset": 15598,
            "parents": [],
            "refoffsets": {
                "bib0075": {
                    "endOffset": 15597,
                    "startOffset": 15590
                },
                "bib0080": {
                    "endOffset": 15597,
                    "startOffset": 15590
                }
            },
            "secId": "sec0005",
            "sentence": "Previous studies conclusively demonstrated the potent immune stimulating properties of live baculovirus in vaccine preparations [15,16].",
            "startOffset": 15462,
            "title": "Introduction"
        },
        {
            "endOffset": 35092,
            "parents": [],
            "refoffsets": {
                "bib0145": {
                    "endOffset": 35091,
                    "startOffset": 35087
                }
            },
            "secId": "sec0085",
            "sentence": "It remains unclear whether the virus will persist in the human reservoir and cause sporadic infections, or whether it will gain the ability to transmit from human to human through mutations or re-assortment [29].",
            "startOffset": 34880,
            "title": "Discussion"
        },
        {
            "endOffset": 41379,
            "parents": [],
            "secId": "sec0085",
            "sentence": "Although virus preparations were standardised, there still might have been slight variations in HA-activity of the viruses utilised.",
            "startOffset": 41247,
            "title": "Discussion"
        },
        {
            "endOffset": 14935,
            "parents": [],
            "refoffsets": {
                "bib0040": {
                    "endOffset": 14934,
                    "startOffset": 14928
                },
                "bib0045": {
                    "endOffset": 14934,
                    "startOffset": 14928
                },
                "bib0050": {
                    "endOffset": 14934,
                    "startOffset": 14928
                },
                "bib0055": {
                    "endOffset": 14934,
                    "startOffset": 14928
                },
                "bib0060": {
                    "endOffset": 14934,
                    "startOffset": 14928
                },
                "bib0065": {
                    "endOffset": 14934,
                    "startOffset": 14928
                },
                "bib0070": {
                    "endOffset": 14934,
                    "startOffset": 14928
                }
            },
            "secId": "sec0005",
            "sentence": "The exceptional adaptive ability of the virus and the lack of human pre-immunity and of available vaccines underline the necessity of rapid measures to be taken and research on the development on human H7 vaccines is underway [8\u201314].",
            "startOffset": 14702,
            "title": "Introduction"
        },
        {
            "endOffset": 27853,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "sec0055",
            "sentence": "The colorimetric change was measured as the optical density (OD 490 nm) on a Synergy 4 (BioTek, Winooski, VT) microplate reader.",
            "startOffset": 27725,
            "title": "ELISA assays"
        },
        {
            "endOffset": 40180,
            "parents": [],
            "refoffsets": {
                "bib0210": {
                    "endOffset": 40179,
                    "startOffset": 40175
                }
            },
            "secId": "sec0085",
            "sentence": "Interestingly, cross-reactivity to H10, which is phylogenetically closer to H7 than H3, was only slightly above the background signal for the 3 \u03bcg dose group (Fig. 2), which is in agreement with results recently obtained by Muramatsu and colleagues [42].",
            "startOffset": 39926,
            "title": "Discussion"
        },
        {
            "endOffset": 27724,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "sec0055",
            "sentence": "Unbound antibody was removed by three washes with 100 \u03bcL PBST and plates were developed using SigmaFAST OPD substrate (Sigma, St. Louis, MO) (100 \u03bcL/well) and stopped with 3 M HCl (50 \u03bcL/well).",
            "startOffset": 27531,
            "title": "ELISA assays"
        },
        {
            "endOffset": 38728,
            "parents": [],
            "refoffsets": {
                "bib0200": {
                    "endOffset": 38727,
                    "startOffset": 38723
                }
            },
            "secId": "sec0085",
            "sentence": "CD8+-depleted mice were fully protected in the challenge experiment and showed similar weight loss kinetics as observed for non-depleted mice (Fig. 1B and D), which is in agreement with previous findings [40].",
            "startOffset": 38519,
            "title": "Discussion"
        },
        {
            "endOffset": 38973,
            "parents": [],
            "refoffsets": {
                "bib0130": {
                    "endOffset": 38776,
                    "startOffset": 38772
                }
            },
            "secId": "sec0085",
            "sentence": "However, in a recent work by Hemann et al. [26], only 60% survival of CD8+-depleted mice that received a single dose of an influenza H1-VLP vaccine was reported in a homologous challenge experiment after intranasal vaccination with 2.5 \u03bcg VLPs.",
            "startOffset": 38729,
            "title": "Discussion"
        },
        {
            "endOffset": 31022,
            "parents": [
                {
                    "id": "sec0065",
                    "title": "Results"
                }
            ],
            "secId": "sec0070",
            "sentence": "Mice that received two immunisations with 0.3 \u03bcg SH1, expectedly showed a 100% survival rate and little weight loss (Fig. 1A and C).",
            "startOffset": 30890,
            "title": "Efficacy of H7-VLPs in an in vivo mouse challenge experiment"
        },
        {
            "endOffset": 36251,
            "parents": [],
            "secId": "sec0085",
            "sentence": "Furthermore, the overall majority of H7 vaccines in the pipeline are focused on egg-based production which might be an inadequate platform in a pandemic setting due to limited manufacturing capacities and longer production times compared to cell-culture based systems.",
            "startOffset": 35983,
            "title": "Discussion"
        },
        {
            "endOffset": 18823,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "sec0020",
            "sentence": "Viruses were propagated in 8- to 10-day-old specific pathogen-free embryonated chicken eggs (Charles River Laboratories) for 48 h at 37 \u00b0C and virus was titred on MDCK cells in the presence of tosyl phenylalanyl chloromethyl ketone (TPCK) treated trypsin.",
            "startOffset": 18568,
            "title": "Viruses"
        },
        {
            "endOffset": 40897,
            "parents": [],
            "secId": "sec0085",
            "sentence": "HI-active antibodies could be detected for the vaccine strains but also for a panel of divergent H7 viruses, which included representatives of the Eurasian and the North American lineage (Table 1).",
            "startOffset": 40700,
            "title": "Discussion"
        },
        {
            "endOffset": 28350,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "sec0060",
            "sentence": "Serum samples were treated with 4 volumes of a receptor-destroying enzyme of Vibrio cholera filtrate (Sigma, St. Louis, MO) for 18 h at 37 \u00b0C.",
            "startOffset": 28208,
            "title": "Hemagglutination inhibition assay"
        },
        {
            "endOffset": 36740,
            "parents": [],
            "secId": "sec0085",
            "sentence": "It is highly desirable to obtain good efficacy already with low vaccine doses and the fewest possible injections to prevent shortages.",
            "startOffset": 36606,
            "title": "Discussion"
        },
        {
            "endOffset": 37891,
            "parents": [],
            "refoffsets": {
                "bib0080": {
                    "endOffset": 37890,
                    "startOffset": 37886
                }
            },
            "secId": "sec0085",
            "sentence": "It was shown that baculovirus can enhance immunogenicity of VLP vaccines through boosting the immune response by interferon-signalling and biasing IgG isotype distribution [16].",
            "startOffset": 37714,
            "title": "Discussion"
        },
        {
            "endOffset": 33753,
            "parents": [
                {
                    "id": "sec0065",
                    "title": "Results"
                }
            ],
            "secId": "sec0080",
            "sentence": "Levels of neutralising antibodies elicited by each vaccine were measured by hemagglutination inhibition (HI) assay in which sera from vaccinated mice were evaluated for their ability to prevent virus-induced agglutination of turkey RBCs.",
            "startOffset": 33516,
            "title": "H7 VLPs induce cross-reactive HI active antibody responses"
        },
        {
            "endOffset": 24562,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "sec0050",
            "sentence": "Animals had free access to food and water and were kept on a 12-h light/dark cycle.",
            "startOffset": 24479,
            "title": "Mouse immunisation and challenge"
        },
        {
            "endOffset": 31422,
            "parents": [
                {
                    "id": "sec0065",
                    "title": "Results"
                }
            ],
            "secId": "sec0070",
            "sentence": "Mice in the prime-only vaccination groups that received lower vaccine doses (0.3 \u03bcg and 0.03 \u03bcg) showed more weight loss (7% and 10%, respectively) than mice in the high dose or prime-boost groups (both 3%), but the mice were completely protected from mortality and regained weight after day 5 post challenge (Fig. 1A and C).",
            "startOffset": 31097,
            "title": "Efficacy of H7-VLPs in an in vivo mouse challenge experiment"
        },
        {
            "endOffset": 20780,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "sec0030",
            "sentence": "After electrophoretic transfer onto polyvinylidene difluoride (PVDF) membranes (Thermo Fisher Scientific, Waltham, MA), the membranes were blocked for 1 h in PBS containing 0.1% Tween 20 (v/v) (PBST) and 3% (w/v) non-fat dry milk powder.",
            "startOffset": 20543,
            "title": "Western blot analysis and HA quantification"
        },
        {
            "endOffset": 16575,
            "parents": [],
            "secId": "sec0005",
            "sentence": "We also detected sero-reactivity to heterosubtypic members of the group 2 HAs, such as H15 and H3.",
            "startOffset": 16477,
            "title": "Introduction"
        },
        {
            "endOffset": 43797,
            "parents": [],
            "refoffsets": {
                "bib0230": {
                    "endOffset": 43732,
                    "startOffset": 43725
                },
                "bib0235": {
                    "endOffset": 43732,
                    "startOffset": 43725
                }
            },
            "secId": "sec0090",
            "sentence": "As a large body of research is currently focusing on baculovirus-based expression systems in vaccine manufacturing, more safety data will accumulate and more analytical methods will become available for this system in the near future [46,47] and might possibly spur its establishment in human applications.",
            "startOffset": 43491,
            "title": "Conclusion"
        },
        {
            "endOffset": 26988,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "sec0055",
            "sentence": "Briefly, Immulon 4HBX\u00ae ultra-high-binding polystyrene plates (Thermo Fisher Scientific, Waltham, MA) were coated with rHA at a concentration of 2 \u03bcg/mL in coating buffer (0.1 M Na2CO3/NaHCO3, pH 9.2, 50 \u03bcL/well) at 4 \u00b0C overnight.",
            "startOffset": 26758,
            "title": "ELISA assays"
        },
        {
            "endOffset": 29158,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "sec0060",
            "sentence": "Divergent H7 strains were assayed with pooled sera.",
            "startOffset": 29107,
            "title": "Hemagglutination inhibition assay"
        },
        {
            "endOffset": 22382,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "sec0035",
            "sentence": "Hemagglutination units (HAU) are read as the reciprocal of the last dilution, giving rise to hemagglutination of red blood cells.",
            "startOffset": 22253,
            "title": "Hemagglutination assay"
        },
        {
            "endOffset": 15146,
            "parents": [],
            "secId": "sec0005",
            "sentence": "Here, we assess the efficacy of a single low vaccine dose of influenza A H7 virus-like particles (VLPs) of Avian Influenza A (H7N9) virus origin to protect against a stringent viral challenge in the mouse model.",
            "startOffset": 14935,
            "title": "Introduction"
        },
        {
            "endOffset": 38082,
            "parents": [],
            "secId": "sec0085",
            "sentence": "Vaccination with VLPs harbouring an HA from a closely related (but phylogenetically distinct) H7 strain, A/Anhui/1/13, also protected mice from PR8:SH1 challenge after only one immunisation.",
            "startOffset": 37892,
            "title": "Discussion"
        },
        {
            "endOffset": 35697,
            "parents": [],
            "secId": "sec0085",
            "sentence": "The potential threat of a pandemic outbreak serves as catalyst for enhanced research and vaccine development efforts in both academia and industry.",
            "startOffset": 35550,
            "title": "Discussion"
        },
        {
            "endOffset": 19447,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "sec0025",
            "sentence": "Empty VLPs consisting of M1 only were prepared to be used as a negative control.",
            "startOffset": 19367,
            "title": "Production of virus-like particles in insect cells"
        },
        {
            "endOffset": 31796,
            "parents": [
                {
                    "id": "sec0065",
                    "title": "Results"
                }
            ],
            "secId": "sec0070",
            "sentence": "Animals that received an M1-only preparation containing similar amounts of baculovirus as the SH1- and AH1-VLP preparation showed no enhanced protection as compared to na\u00efve mice (Fig. 1A and C).",
            "startOffset": 31601,
            "title": "Efficacy of H7-VLPs in an in vivo mouse challenge experiment"
        }
    ],
    "docId": "S0264410X13015533",
    "metadata": {
        "asjc": [
            "1313",
            "2400",
            "2725",
            "2739",
            "3400"
        ],
        "authors": [
            {
                "email": null,
                "first": "Miriam",
                "initial": "M.",
                "last": "Klausberger"
            },
            {
                "email": null,
                "first": "Monika",
                "initial": "M.",
                "last": "Wilde"
            },
            {
                "email": null,
                "first": "Dieter",
                "initial": "D.",
                "last": "Palmberger"
            },
            {
                "email": null,
                "first": "Rong",
                "initial": "R.",
                "last": "Hai"
            },
            {
                "email": null,
                "first": "Randy A.",
                "initial": "R.A.",
                "last": "Albrecht"
            },
            {
                "email": null,
                "first": "Irina",
                "initial": "I.",
                "last": "Margine"
            },
            {
                "email": null,
                "first": "Ariana",
                "initial": "A.",
                "last": "Hirsh"
            },
            {
                "email": null,
                "first": "Adolfo",
                "initial": "A.",
                "last": "Garc\u00eda-Sastre"
            },
            {
                "email": null,
                "first": "Reingard",
                "initial": "R.",
                "last": "Grabherr"
            },
            {
                "email": "Florian.Krammer@mssm.edu",
                "first": "Florian",
                "initial": "F.",
                "last": "Krammer"
            }
        ],
        "doi": "10.1016/j.vaccine.2013.11.036",
        "firstpage": "355",
        "issn": "0264410X",
        "keywords": [
            "Baculovirus",
            "Cross-reactivity",
            "H7N9",
            "Influenza",
            "Pandemic",
            "Virus-like particle"
        ],
        "lastpage": "362",
        "openaccess": "Full",
        "pub_year": 2014,
        "subjareas": [
            "BIOC",
            "IMMU",
            "MEDI",
            "VETE"
        ],
        "title": "One-shot vaccination with an insect cell-derived low-dose influenza A H7 virus-like particle preparation protects mice against H7N9 challenge"
    }
}